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1 Introduction
Mycobacterium tuberculosis
 is a leading pathogen worldwide, infecting an
estimated 8 million and killing 2 – 3 million people each year (Dye et al.,
1999). In addition, it is estimated that ~ 2 billion people have been exposed
to M. tuberculosis, and thus are at risk of developing the active disease. Al-
though most of the infected individuals reside in less industrialized countries,
the rates of infection are also increasing at an alarming rate in areas under-
going rapid social change, such as the countries of the former Soviet Union
(Keshavjee and Becerra, 2000). In part because of the symbiotic relationship
between human immunodeficiency virus (HIV) and tuberculosis, and be-
cause of the increasingly rapid displacement of populations, the incidence of
multi-drug-resistant (MDR) tuberculosis is an important worldwide concern.
Thus, in a survey of 35 countries, 12.6 % of M. tuberculosis isolates were
found to be resistant to at least one drug, and 2.2 % were resistant to both
isoniazid and rifampicin, the two primary drugs used to treat tuberculosis
(Pablos-Mendez et al., 1998). This resurgence of tuberculosis has led to re-
newed efforts to find new drugs for the treatment of this dreaded disease,
particularly agents that exhibit activity against drug-resistant strains, com-
pletely sterilize the infection, or shorten the duration of drug therapy and thus
promote drug compliance.
1.1 Epidemiology
Tuberculosis (TB) is a worldwide public health problem and is usually
transmitted by droplet infection. As noted previously, approximately one third
of the earth’s population is infected with M. tuberculosis. Although less than
ten per cent become sick, in 1995 more humans died of tuberculosis than
ever before. An increasing drug resistance problem coupled with the HIV-
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induced acquired immunodeficiency syndrome is leading to further epidemic
spread among population. The common infectious agent is M. tuberculosis,
more rarely Mycobacterium bovis, Mycobacterium africanum, Mycobacterium
microti, and the newly discovered Mycobacterium canettii (Pfyffer et al.,
1998; Am. Thorac. Soc., 2003). In about 85 % of all clinical cases the lung is
involved. However, with the increase of the HIV infections, the proportion of
extra-pulmonary types is on the increase. In 1997, 8 million new TB cases
were assessed, adding to 16 million cases already registered. Of the latter,
approximately 2 million could have died since then (Dye et al., 1999). Some
80 % of all patients were registered in 22 countries. More than half of them
were from five nations belonging to the southeast region of Africa (Fig. 1.1).
Not surprisingly, 9 out of 10 of the highest incidences are located in that
continent (Dye et al., 1999). This situation is likely to deteriorate in the fu-
ture. The World Health Organization (WHO) expects an increase of the an-
nual disease rates from 8 million in 1997 to 10.2 million per year in 2005
(WHO, 2001). This alarming sign of the spreading of an endemic disease
and the fact that drug resistant strains have emerged on a massive scale
underscore the importance of studying mycobacterial defense mechanisms.
Although scientific breakthroughs in the field have been rare, the release of
the complete genome sequence of M. tuberculosis (Cole et al., 1998) has
initiated a hunt for genes of interest for vaccine development, either as tar-
gets for gene knockout or as candidates for protective antigens.
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Fig. 1.1: Tuberculosis (TB) notification rates and estimated TB incidence rates in
2000. The 202 countries reporting to WHO notified a total of 3,671,973 cases (61 per
100,000 population). This represents only one quarter (27 %) of the estimated total
(WHO, 2002).
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1.2 Infection and disease
Tuberculosis is caused by the acid-fast, rod shaped bacillus, Mycobacterium
tuberculosis. The microorganism is shielded by a unique wax-rich cell wall
that is composed of long-chain fatty acids, glycolipids and other compo-
nents. Accordingly, approximately 250 genes within the M. tuberculosis ge-
nome are involved in the fatty-acid metabolism. The robust shell contributes
to the capacity of M. tuberculosis to survive in host phagocytes. M. tubercu-
losis
 is a slow-growing organism, with a replication time of approximately 20
hours. This slow growth forms the basis for the chronic nature of infection
and disease, complicates microbiological diagnosis and necessitates long-
term drug treatment.
In clinical terms tuberculosis is divided into primary (I) and reactivated forms
(II).
(I) The typical source of a primary infection is a person with pulmonary tu-
berculosis producing up to 3,000 aerosol droplets per cough attack (Fig.
1.2). A primary infection need not be fatal and can be treated with appropri-
ate chemotherapy. However, on occasions (AIDS etc.) the illness will not
stay localized but can progress and the person will suffer from secondary
complications. Generally, incorporated mycobacteria can survive after
phagocytosis by macrophages. To do so, they must be able to resist many
cellular defense strategies in the human body: reactive oxygen species and
nitrogen compounds as well as enzyme acitivities such as myeloperoxi-
dases, phosphatases, hydrolases, proteases, lysozyme, and lipases. In par-
ticular, the lipid-rich cell wall plays an important role as protective layer
against aggressive lysosomal factors and as a diffusion barrier against
drugs.
(II) Reactivated tuberculosis is a recurrence of the pulmonary form after sen-
sitization to M. tuberculosis during the primary infection: after an interval of
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latency, a cellular immune response leads to the formation of tissue tumors
(granuloma) (Fig. 1.2). These highly characteristic pathological lesions are
also known as tubercles. Tissue destruction (fibrosis) presents focal areas
with dead cells (necrosis), forming a friable and amorphous granular mass,
cheese-like in appearance (caeseous detritus). Often these foci show spon-
taneous remission; otherwise they become calcified. However, on occasion
such material is liberated into the bronchioles of the respiratory tract and is
expectorated. Subsequently, the aspiration can cause inflammation of the
lungs, known as tuberculous pneumonia. Alternatively, the material persists
in cavities as encapsulated tuberculosis (Rubin and Farber, 1999).
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Fig. 1.2: Main features of tuberculosis: from infection to host defense. There are
three potential outcomes of infection of the human host in M. tuberculosis. a) The fre-
quency of abortive infection resulting in spontaneous healing is unknown, but is assumed
to be minute. b) In the immunocompromised host, disease can develop directly after in-
fection. c) In most cases, mycobacteria are initially contained and disease develops later
as a result of reactivation. The granuloma is the site of infection, persistence, pathology
and protection. Effector T cells (including conventional CD4+ and CD8+ T cells, and un-
conventional T cells, such as γδ T cells, and double-negative or CD4/CD8 single-positive
T cells that recognize antigen in the context of CD1) and macrophages participate in the
control of tuberculosis. Interferon-γ (IFN-γ) and tumour-necrosis factor-α (TNF-α), pro-
duced by T cells, are important macrophage activators. Macrophage activation permits
phagosomal maturation and the production of antimicrobial molecules such as reactive
nitrogen intermediates (RNI) and reactive oxygen intermediates (ROI). LT-α3, lympho-
toxin-α3 (Kaufmann, 2001).
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1.3 The intracellular lifestyle of M. tuberculosis
M. tuberculosis
 uses macrophages as its preferred habitat, which has two
important implications for its survival (Schaible et al., 1999). First, macro-
phages, as professional phagocytes, are endowed with several surface re-
ceptors that facilitate antigen uptake, thereby rendering specific host-
invasion strategies dispensable (Ernst, 1998; Ehlers and Daffe, 1998). Cho-
lesterol has been shown to act as a docking site for the pathogen, promoting
receptor-ligand interactions (Gatfield and Pieters, 2000). The initial interac-
tion with surface receptors influences the subsequent fate of M. tuberculosis
within the macrophage. Interactions with the constant regions of immun-
globulin receptors and Toll-like receptors stimulate host-defense mecha-
nisms, whereas those with complement receptors promote mycobacterial
survival (Armstrong and Hart, 1975; Schorey et al., 1997; Brightbill et al.,
1999; Thoma-Uszynski et al., 2001). The second consequence, which war-
rants more sophisticated coping mechanisms, is the survival of M. tubercu-
losis
 within the phagosome, as this constitutes a harsh environment that is
detrimental to many microbes (Schaible et al., 1999). M. tuberculosis over-
comes this obstacle by arresting the phagosome at an early stage of matu-
ration, and by preventing fusion of the phagosome with lysosomes
(Armstrong and Hart, 1975; Russell et al., 1996; Harth and Horwitz, 1999;
Ferrari et al., 1999).
The arrest of phagosomal maturation is not an all-or-nothing event. Some
mycobacterial phagosomes can proceed to develop to the more mature
stages of the phagolysosome. Phagosomal maturation is promoted by acti-
vation with interferon-γ (IFN-γ), which stimulates anti-mycobacterial mecha-
nisms in macrophages (Fig. 1.2), notably the formation of reactive oxygen
intermediates (ROI) and reactive nitrogen intermediates (RNI) (Schaible et
al., 1998; Schaible et al., 1999). However, even IFN-γ-activated macro-
phages fail to fully eradicate their resident M. tuberculosis (Kaufmann,
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1999). Persistent microbes might proceed to a stage of dormancy with a re-
duced metabolic activity that facilitates their survival under conditions of nu-
trient and oxygen deprivation. These bacteria can persist without producing
disease and therefore create a state of latency. Nevertheless, the risk of
disease outbreak at a later time remains. In vitro experiments indicate that
mycobacteria switch to lipid catabolism and nitrate respiration to ensure their
survival (McKinney et al., 2000; Weber et al., 2000). Lipids are abundant in
the caeseous detritus of granulomas, providing a rich source of nutrients
during persistence.
1.4 Drug-resistant tuberculosis
Most forms of drug resistance are iatrogenic by their nature, i.e. acquired
during pharmacotherapy. The most common causes leading to the selection
of drug-resistant strains among microorganisms are: (i) administration of a
single drug (instead of a combination), (ii) sub-therapeutic dosage below the
pharmacologically required minimum inhibiting concentration (MIC), (iii)
treatment applied for too short a time period, (iv) non-compliance of patients,
(v) socio-economical problems, circumstances under which poor people
strive to obtain medical assistance, (vi) insufficient regional drug availability,
and (vii) lack of dispensation facilities and professional pharmaceutical care
(Crofton et al., 1997).
A typical clinical case of drug resistant tuberculosis would be one of the
pulmonary types, in which the patient spreads resistant bacilli. Resistance
implies lack of any anti-infectious effects at least for the front line drugs (in
decreasing or increasing order of efficiency or toxicity, respectively): isonia-
zid (isonicotinic acid hydrazide, INH), rifampicin (rifampin, RMP), pyrazina-
mide, ethambutol, and streptomycin. Second-line drugs are protionamide,
ethionamide, thiacetazone, thiocarlide, cycloserine, capreomycine, and
paraaminosalicylic acid. Those are all bacteriostatic in action whereas the
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primary-line drugs are bactericidal. Overall, some form part of the recom-
mended treatment for tuberculosis issued by the WHO. Due to the required
administration of antituberculous agents for prolonged durations (several
months to years), resistance has rapidly developed in 5 – 10 % of the strains
(1 – 3 % multidrug resistant disease). To avoid selection of even more pri-
marily resistant bacteria the WHO recommends a treatment scheme within
their DOTS (Directly Observed Treatment Short-Course) program. That con-
sists of a two-months treatment with a combination of 4 antibiotics including
isoniazid, rifampicin, and pyrazinamide, complemented with either strepto-
mycin or ethambutol. It is followed by a 6-months treatment with isoniazid,
combined with either ethionamide or ethambutol, or a 4-months treatment
with isoniazid and rifampicin (WHO, 1998; WHO, 1999).
Shortly after the introduction of isoniazid chemotherapy in 1952, mycobacte-
ria resistant to that antituberculous agent were described (Middlebrook,
1952). Nevertheless, isoniazid has remained as the basic medication. The
mode of action of isoniazid is not fully understood, but there is evidence that
certain isoniazid-resistant strains of mycobacteria have reduced cata-
lase/peroxidase (KatG) enzyme activity. It suggests that the antibiotic is
acted upon by that enzyme and, therefore, isoniazid is a prodrug (Zhang et
al., 1992; Johnsson and Schultz, 1994; Johnsson et al., 1995). Expression of
KatG is a requirement for bacterial sensitivity to isoniazid (Zhang et al.,
1992; Zhang et al., 1993). In its active form, isoniazid generates a range of
reactive oxygen species and reactive organic radicals, which then attack
multiple targets (DNA, carbohydrates, lipids) in the tubercle bacillus
(Winder, 1982). The most well known target is the cell wall mycolic acid
synthesis pathway (Winder and Collins, 1970; Banerjee et al., 1994; Mdluli
et al., 1998). Mutations in katG, inhA (acyl carrier protein-enoyl reductase),
and ndh (NADH dehydrogenase, resulting in an increased NADH/NAD+ ra-
tio), cause isoniazid resistance (Zhang et al., 1992; Banerjee et al., 1994;
Lee et al., 2001). Point mutations or deletions in katG are the most common
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mechanism of isoniazid resistance in M. tuberculosis clinical isolates (Heym
et al., 1994; Musser, 1995; Musser et al., 1996; Rouse et al., 1996; Heym
and Cole, 1997). Isolates most resistant to isoniazid tend to carry mutations
that severely reduce or eliminate KatG-peroxidase activity, whereas M. tu-
berculosis
 mutants that retain some percent of peroxidase activity remain
moderately resistant to isoniazid. In addition, introduction of M. tuberculosis
katG
 into isoniazid-resistant mutants restores innate susceptibility to this
drug (Zhang et al., 1992; Zhang and Young, 1993; Heym et al., 1995; Rouse
and Morris, 1995).
1.5 Oxidative stress response in M. tuberculosis
In addition to its role in the activation of isoniazid, KatG is thought to play
another key role in the infection with the tubercle bacillus. As intracellular
pathogens capable of surviving and multiplying within host macrophages,
mycobacteria have to survive exposure to macrophage killing mechanisms,
including the oxidative stress response (see 1.3). The catalase/peroxidase
KatG is a component of the bacterial OxyR response, which is induced by
oxidative stress and protects the bacteria against oxidative killing (Storz et
al., 1990; Farr and Kogoma, 1991; Aslund et al., 1999; Zahrt and Deretic,
2002). Thus, the loss of a functional KatG in isoniazid-resistant strains of M.
tuberculosis
 would be expected to lead to a reduced ability of the pathogen
to survive within the intracellular environment; indeed it was reported many
years ago that isoniazid resistance was associated with loss of virulence in
the guinea pig (Middlebrook and Cohn, 1953).
It was found that the gene encoding the OxyR transcription factor of M. tu-
berculosis
 is defective as a result of a number of mutations, and with the ex-
ception of KatG, M. tuberculosis does not have a peroxide-inducible re-
sponse (Sherman et al., 1995; Deretic et al., 1995). However, some isonia-
zid-resistant katG mutants compensate their loss of catalase/peroxidase ac-
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tivity by overexpression of the alkyl hydroperoxide reductase AhpC (alkyl
hydroperoxide reductase subunit C). Thus, it has been claimed that during
infection with isoniazid-resistant, KatG-deficient M. tuberculosis, there is a
selection for compensatory ahpC promoter mutations, enabling the organ-
isms to grow intracellularly (Sherman et al., 1996; Sherman et al., 1999).
The mycobacterial ahpC gene encodes an orthologue of bacterial alkyl hy-
droperoxidases (Christman et al., 1985; Jacobson et al., 1989; Sherman et
al., 1996; Dhandayuthapani et al., 1996; Sreevatsan et al., 1997; Heym et
al., 1997; Wilson et al., 1998; Pagan-Ramos et al., 1998; Chen et al., 1998;
Cooper et al., 2000; Springer et al., 2001). In most mycobacteria, the ahpC
gene is linked to oxyR and is activated by its gene product, an orthologue of
the global regulator OxyR, controlling the peroxide stress. As mentioned
previously, in M. tuberculosis as a species, and in all members of the M. tu-
berculosis
 complex, the oxyR gene is inactivated and represents a pseudo-
gene. Recently it was shown that there exists a second level of ahpC regu-
lation independent of oxyR. The ahpC gene is silenced in aerobic cultures of
virulent M. tuberculosis, but is activated in statically grown organisms
(Springer et al., 2001; Master et al., 2002). AhpC has been indirectly impli-
cated in nitric oxide metabolism using expression in heterologous systems
like Salmonella (Chen et al., 1998). Purified AhpC has been shown to reduce
hydroperoxides (Hillas et al., 2000; Chauhan and Mande, 2001) and has
also been suggested to have peroxynitrite reductase activity (Bryk et al.,
2000).
1.6 The peroxiredoxin family
The mycobacterial AhpC belongs to a family of bacterial and eukaryotic an-
tioxidant proteins with alkyl hydroperoxidase (Ahp) and thioredoxin-
dependent peroxidase (TPx) activities. The two are peroxiredoxin-type per-
oxidases. Peroxiredoxins (Prxs) are a new and expanding family of thiol-
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specific antioxidant proteins, also termed the thioredoxin peroxidases and
alkyl hydroperoxide reductase proteins (Chae et al., 1994a; Chae et al.,
1994b; Schroeder and Ponting, 1998). Prxs exert their protective antioxidant
role in cells through their peroxidase activity (ROOH + 2e− → ROH + H2O),
whereby hydrogen peroxide, peroxynitrite and a wide range of organic hy-
droperoxides (ROOH) are reduced and detoxified (Jacobson et al., 1989;
Poole and Ellis, 1996; Bryk et al., 2000; Peshenko and Shichi, 2001; Hof-
mann et al., 2002; Wood et al., 2003a). Peroxiredoxins are proteins without
any prosthetic group. The only redox-active residues are cysteines. Their
sequences classify them as a distinct protein family that is unrelated to any
of the other peroxidase families. As a rule, the catalytic cycle of peroxire-
doxins makes use of redox shuttling of one or two cysteine residues. These
enzymes are truly ubiquitous having been identified in yeast, plant and ani-
mal cells, including both protozoan and helminth parasites, and most, if not
all, eubacteria and archaea. Prxs are produced at high levels in cells (Moore
et al., 1991; Link et al., 1997; Chae et al., 1999), and many organisms pro-
duce more than one isoform of Prx, including at least six Prxs identified in
mammalian cells (Wood et al., 2003a).The high abundance of Prxs in a wide
range of species and a recent finding that AhpC and not catalase is respon-
sible for reduction of endogenously generated H2O2 in Escherichia coli
(Seaver and Imlay, 2001) provide a persuasive argument that Prxs are im-
portant players in peroxide detoxification in cells. In addition, Baker and
Poole reported very recently, that E. coli thiol peroxidase (TPx), also a
member of the Prx family, is part of an oxidative defense system that uses
reducing equivalents from thioredoxin and thioredoxin reductase to reduce
alkyl hydroperoxides (Baker and Poole, 2003), and tpx mutation studies in
Helicobacter pylori
 showed that TPx plays a significant role in peroxide and
superoxide resistance of H. pylori (Comtois et al., 2003).
In enterobacteria AhpC, together with the flavine-containing disulfide reduc-
tase AhpF (alkyl hydroperoxide reductase subunit F), forms a two-
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component system achieving hydroperoxide reduction by NAD(P)H without
the aid of auxiliary enzymes or low molecular weight redox mediators (Fig.
1.3; Jacobson et al., 1989; Storz et al., 1989). In E. coli and Salmonella ty-
phimurium
 AhpF and AhpC are jointly regulated by the oxyR regulon that
responds to oxidative stress and determines hydroperoxide resistance (Zahrt
and Deretic, 2002). While AhpC appears to be ubiquitous in bacteria
(Hofmann et al., 2002), AhpF is not. H. pylori lacks AhpF. Instead, H. pylori
uses a thioredoxin (Trx) as the reductant of AhpC (Fig. 1.3) (Baker et al.,
2001). In contrast to enterobacteria, M. tuberculosis does not respond to
oxidative stress with overexpression of AhpC (Dhandayuthapani et al.,
1996), but AhpC is constitutively overexpressed in isoniazid-resistant clinical
isolates. The resistance to isoniazid is due to a deficiency of catalase, which
is required to activate the drug (see 1.4 and 1.5). Also mycobacteria do not
contain a functional AhpF. That indicates that M. tuberculosis normally relies
on catalase for H2O2 detoxification but depends on AhpC if catalase is
missing.
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Fig. 1.3: Examples of bacterial antioxidant defense systems. Homologous proteins
are shown in identically coloured circles. H. pylori makes use of the Trx-system for re-
duction of Prx-type AhpC like mammals and many other organisms. In enterobacteria
AhpC is directly reduced by a flavin-dependent disulfide reductase. In mycobacteria
AhpC reduction appears to be linked to energy metabolism. They also contain a thiore-
doxin system, further glutaredoxin-like proteins and mycothiol as low molecular weight
redox mediator. The role of these redox systems in antioxidant defense is still unclear
(Budde and Flohé, 2002). AhpC, alkyl hydroperoxe reductase subunit C; AhpD, alkyl
hydroperoxide reductase subunit D; AhpF, alkyl hydroperoxide reductase subunit F; Lpd,
dihydrolipoamide dehydrogenase; MycR, mycothiol reductase; MSH, mycothiol; SucB,
dihydrolipoamide succinyltransferase; Trx, thioredoxin; TrxR, thioredoxin reductase
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1.7 Objectives of the study
At the beginning of this thesis it was unclear how AhpC is reduced in myco-
bacteria. Attempts to substitute the missing AhpF by homologous mycothiol
reductase and mycothiol or a thioredoxin/thioredoxin reductase system have
failed so far (Hillas et al., 2000; Vergauwen et al., 2001). More recently, a
quite unique link of AhpC to mycobacterial energy metabolism was proposed
(Bryk et al., 2002): The reduction equivalents are transferred by two compo-
nents of the α-keto acid dehydrogenase complex [dihydrolipoamide dehy-
drogenase (Lpd) and dihydrolipoamide succinyltransferase (SucB)] to AhpD
(alkyl hydroperoxide reductase subunit D) that, like thioredoxins, contains a
CXXC motif and thus substitutes for a real thioredoxin in AhpC reduction.
The low molecular weight thiol that often mediates the flux from the flavo-
proteins to CXXC proteins is replaced here by SucB-bound lipoic acid (Fig.
1.3).
The objectives of this study were to:
•
 search for more likely metabolic partner of the mycobacterial AhpC,
•
 screen the genome of M. tuberculosis (Cole et al., 1998) for homologues
of AhpF, thioredoxin-related proteins and peroxiredoxins,
•
 express the genes heterologously, and
•
 attempt to reconstitute peroxidase systems from the isolated gene prod-
ucts in vitro and examine their efficiencies by kinetic analysis.
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2 Materials and Methods
2.1 Chemicals and reagents
Most of the chemicals purchased were of the highest purity grade available
and were from:
(
 J. T. Baker B. V., Deventer, Netherlands
(
 Merck, Darmstadt, Germany
(
 Serva Electrophoresis, Heidelberg, Germany
(
 Sigma-Aldrich, Taufenkirchen, Germany
(
 Roche, Mannheim, Germany
2.2 Bacterial strains, plasmids and culture procedures
2.2.1 Strains
2.2.1.1 E. coli strains
The E. coli strains used in this study and their characteristics are listed in
Table 2.1. All strains were grown in LB medium or on LB agar (see Table
2.3).
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Table 2.1: E. coli strains and their characteristics
strain genotype and relevant phenotype origin / reference
E. coli DH5α
supE44 ∆lacU169(Φ80 lacZ ∆M15)
hsdR17 recA1 endA1 gyrA96 thi-1 relA1
(Hanahan, 1983)
E. coli BL21 (DE3) F- ompT hsdSB (rB- mB-) gal dcm (DE3)
Novagen (Madison,
USA)
E. coli Tuner (DE3) F
-
 ompT hsdSB (rB- mB-) gal dcm lacY1
(DE3)
Novagen (Madison,
USA)
2.2.1.2 Mycobacterium strains
All mycobacterium strains used in this study are listed in Table 2.2. The M.
bovis BCG and M. marinum strains were purchased from the Statens Serum
Institut (Copenhagen, Denmark) and the German Collection of Microorgan-
isms and Cell Cultures (DSMZ; Braunschweig, Germany), respectively. Cell
lysates from M. tuberculosis were kindly provided by Clara Espitia (Instituto
de Investigaciones Biomedicas, UNAM, Mexico City, Mexico).
Table 2.2: Mycobacterium strains and their origin
strain code / ATCC no. origin
M. bovis BCG Chicago;
DSMZ 43990
ATCC 27289 DSMZ, Braunschweig, Ger-
many
M. bovis BCG Copenhagen Danish strain 1331 Statens Serum Institut, Co-
penhagen, Denmark
M. marinum; DSMZ 44344 ATCC 927 DSMZ, Braunschweig, Ger-
many
M. marinum; DSMZ 44345 ATCC 11567 DSMZ, Braunschweig, Ger-
many
M. tuberculosis H37Rv ATCC 25618 C. Espitia, Mexico City,
Mexico
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2.2.1.3 Plasmids
For cloning and heterologous expression the E. coli expression vector
pET22b(+) (Novagen, Madison, USA) was used. This 5.5 kb vector carries
an N-terminal pelB signal sequence for potential periplasmic localization, T7
promoter and terminator, lac operator, pBR322 ori, ampicillin resistance plus
optional C-terminal His-tag and is IPTG inducible. The vector pTrcHis A (In-
vitrogen, Karlsruhe, Germany) containing the mycobacterial thioredoxin re-
ductase open reading frame (ORF) fused to an N-terminal 6xHis-tag was
kindly provided by T. H. M. Ottenhoff (Leiden University Medical Centre,
Leiden, Netherlands).
For cloning and expression in mycobacteria the plasmid pMV261 was kindly
provided by Clara Espitia (Instituto de Investigaciones Biomedicas, UNAM,
Mexico City, Mexico). This shuttle plasmid is a 4.5 kb extrachromosomal
plasmid designed to express foreign polypeptides as fusion proteins with
mycobacterial HSP60. A multicloning site is present after the sixth codon of
the HSP60 gene, and expression is under the control of the HSP60 pro-
moter. The aph gene from Tn903 confers kanamycin resistance. Origins of
replication from E. coli pUC19 and mycobacterial pAL5000 are also present
(Stover et al., 1991).
2.2.2 Cultivation of E. coli
The E. coli strain DH5α was used for plasmid transformation and replication.
The strains BL21 (DE3) and Tuner (DE3) were used for heterologous ex-
pression of recombinant proteins. Cultural conditions were 30 ° C – 37 ° C in
LB (Luria-Bertani) medium (Table 2.3) with moderate shaking. For recombi-
nant E. coli strains selection was performed by addition of 200 µg/ml ampi-
cillin to the medium. Bacterial stocks were prepared from a single colony
and stored at -80 ° C in LB broth containing 50 % (v/v) glycerol.
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Table 2.3: Composition of Luria-Bertani (LB) medium
Bacto-Tryptone (Becton Dickinson (BD), Heidelberg, Germany) 10 g/1000 ml
Bacto-Yeast extract (BD, Heidelberg, Germany) 5 g/1000 ml
sodium chloride p.a. 10 g/1000 ml
The pH was adjusted to pH 7.4 with 1 M NaOH. For the preparation of LB agar plates 1.5 % (w/v)
Bacto-Agar (BD, Heidelberg, Germany) was added.
2.2.3 Cultivation of mycobacteria
Culture conditions for M. bovis BCG and M. smegmatis were 37 ° C in
Middlebrook 7H9 liquid medium or on Middlebrook 7H10 agar (Table 2.4)
with moderate shaking of the liquid medium. For recombinant M. smegmatis
selection was performed by addition of 50 µg/ml kanamycin to the medium.
Bacterial stocks were prepared from a single colony and stored at -80 ° C in
Middlebrook 7H9 broth containing 50 % (v/v) glycerol.
The cultures were frequently tested for contamination by acid fast staining
using the ACCUSTAIN Kit (Sigma-Aldrich, Taufenkirchen, Germany).
Table 2.4: Composition of Middlebrook 7H9 medium and 7H10 agar
Middlebrook 7H9 medium:
Bacto-Middlebrook 7H9 Broth (BD, Heidelberg, Germany) 4.7 g/1000 ml
glycerol (87 % (w/v)) 2 ml/1000 ml
Tween 80 5 ml/1000 ml
Bacto-Middlebrook ADC Enrichment (BD, Heidelberg, Germany) 100 ml/1000 ml
Middlebrook 7H10 agar:
Bacto-Middlebrook 7H10 Agar Base (BD, Heidelberg, Germany) 19 g/1000 ml
glycerol (87 % (w/v)) 5 ml/1000 ml
Bacto-Middlebrook OADC Enrichment (BD, Heidelberg, Germany) 100 ml/1000 ml
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2.3 General methods of molecular biology
Standard molecular biology methods were used, essentially according to
Sambrook et al. (2001).
2.3.1 Electrotransformation in E. coli
Electroporation was performed according to Dower et al. (1988).
Electrocompetent cells were prepared as follows: A single clone of E. coli
was incubated in 20 ml LB medium overnight at 37 ° C with moderate
shaking. A volume of 500 ml LB medium was inoculated with 5 ml of this
overnight culture and cultivated at 37 ° C for 2 − 5 hours until an OD600 of
0.6 − 0.8 was reached. The cells were incubated on ice for 30 min and har-
vested (4 ° C, 5000 x g, 15 min). The cells were washed in sequence with
500 ml and 250 ml cold sterile de-ionized water and followed once with ster-
ile 10 % (v/v) glycerol. The pelleted cells were resuspended in 2 ml sterile
10 % (v/v) glycerol, dispensed in 50 µl aliquots and frozen in liquid nitrogen
immediately. The competent cells were stored at -80 ° C for several months.
For electroporation the cells were thawed on ice. 0.1 - 1 µg desalted DNA to
be transformed was added to 50 µl competent cells, mixed well and trans-
ferred to a precooled electroporation cuvette (E. coli Pulser cuvette, 0.2 cm
gap; BioRad, Munich, Germany). Electroporation was carried out at 2.5 kV,
200 Ω and 25 µF with an E. coli Pulser (BioRad, Munich, Germany). 1 ml of
LB medium was added, the cells were incubated at 37 ° C for 1 hour with
moderate shaking and then plated on LB plates containing 200 µg/ml ampi-
cillin.
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2.3.2 Electrotransformation in M. smegmatis
Competent M. smegmatis cells were prepared as desribed for E. coli. The
bacteria were transfected by electroporation (Stover et al., 1991) and selec-
tion was carried out on 7H10 plates containing 50 µg/ml kanamycin (see
2.3.1).
2.3.3 Preparation of plasmid DNA
Plasmid preparations were performed with the QIAprep Spin Miniprep Kit or
the HiSpeed Plasmid Midi Kit (Qiagen, Hilden, Germany) according to the
manufacturers advice.
2.3.4 Purification of genomic DNA from mycobacteria
Mycobacterial cells were disrupted in a Mikro-Dismembranator S (Braun,
Melsungen, Germany) with 100 µl glass beads (150 – 212 microns; Sigma-
Aldrich, Taufenkirchen, Germany). The glass beads were removed and the
cell suspension homogenized with a QIAshredder (Qiagen, Hilden, Ger-
many). Isolation of genomic DNA was done with the Dneasy Tissue Kit
(Qiagen, Hilden, Germany) according to the manual.
2.3.5 Enzymatic DNA restriction
Restriction endo-nucleases were purchased from MBI Fermentas (St. Leon-
Rot, Germany). In each restriction reaction an amount of 3 units enzyme per
1 µg DNA was used. Manufacturer recommended buffer, incubation tem-
perature and time were used.
2 - MATERIALS AND METHODS 22
2.3.6 Ligation
For ligation the molar ratio of insert to plasmid was approximately 3:1. The
reaction was carried out in a total volume of 20 µl T4 DNA ligase buffer
containing 1 unit T4 DNA ligase (Roche, Mannheim, Germany) per 1 µg
DNA. The reaction mixture was incubated at 16 ° C overnight.
2.3.7 Agarose gel electrophoresis of DNA
The separation of DNA by analytical or preparative means was performed at
80 − 100 V in a Wide Mini-Sub Cell or DNA Sub Cell (BioRad, Munich,
Germany). 1x TBE buffer (Table 2.5) was used as the gel and running buffer.
The GeneRuler 1 kb DNA ladder (MBI Fermentas, St. Leon-Rot, Germany)
served as the molecular size marker and 6x Loading Dye Solution (MBI
Fermentas, St. Leon-Rot, Germany) as loading buffer. The agarose gels
were stained with SYBR Gold solution (1:10000 in TBE; Molecular Probes,
Leiden, Netherlands) for 30 min and analyzed with an UV Transilluminator
(E.A.S.Y. RH-3 System; Herolab, Wiesloch, Germany).
Table 2.5: Composition of 1x TBE buffer
89 mM Tris-base
89 mM boric acid
2 mM EDTA
2.3.8 DNA extraction from agarose gels
After separation on agarose gels (see 2.3.7) DNA fragments, obtained from
PCR, were cut out of the gel and extracted with the QIAquick Gel Extraction
Kit (Qiagen, Hilden, Germany) according to the manufacturers advice.
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2.3.9 Ethanol precipitation of DNA
1/10 vol 3 M sodium acetate at pH 4.8 and 2 vol ethanol (p.a.) were added
to the DNA solution. The mixture was incubated on ice for 10 min and after-
wards DNA was precipitated by centrifugation (20000 x g). The DNA pellet
was washed twice with 70 % (v/v) ethanol, dried and resuspended in buffer
or de-ionized H2O.
2.3.10 Quantification of DNA
2.3.10.1 Absorbance measurement
The concentration dependent absorbance of nucleotides at 260 nm can be
used to determine the concentration and purity of DNA solutions. Absorb-
ance of the DNA solution was measured at 260 nm and 280 nm. An OD260 of
1 corresponds to a double stranded DNA concentration of 50 µg/ml. A well
purified DNA solution should have an OD260/OD280 ratio of 1.5 – 2.
2.3.10.2 Quantification of nucleic acids in agarose gels
Alternatively to the method described in 2.3.10.1, the concentration of nu-
cleic acids can be determined in agarose gels (see 2.3.7). Thus, a defined
amount of DNA Mass Ladder (Gibco, Karlsruhe, Germany) was used as a
concentration standard.
2.3.11 Oligonucleotides
Desalted and lyophilized oligonucleotides were custom synthesized by Me-
tabion (Martinsried, Germany). The primers used in this study are listed in
Table 2.6.
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Table 2.6: Primers used in this study
synonym sequence 5’ )  3’
(bold letters indicate the restriction site)
restriction
site
MtMycRFor NNN NNN CTG CAG ATG GAA ACG TAC GAC ATC GCG
ATC
PstI
MtMycRH6Rv NNN NNN AAG CTT TCA GTG ATG GTG ATG GTG ATG
ACG CAG GCC AAG CAG CGC GTT
HindIII
MtRv2466cFor CCC CCC CAT ATG CTC GAG AAG GCC CCC CAG NdeI
MtRv2466cH6Rv CCC CCC GAA TTC CTA GTG GTG GTG GTG GTG GTG
GTC GAA CTG AGG CGG CTC GGT
EcoRI
MtAhpCFor G GCG CGC CAT ATG CCA CTG CTA ACC ATT GGC GA NdeI
MtAhpCH6Rv CCG GCG GGA TCC TTA GTG GTG GTG GTG GTG GTG
GGC CGA AGC CTT GAG GAG TT
BamHI
MtTrxAFor CCC CCC CAT ATG TGT ACC ACT CGA GAC CTC ACG NdeI
MtTrxAH6Rv CCC CCC GAA TTC TCA GTG ATG GTG ATG GTG ATG
GGA TGA AGT CTT TGT TCC AGG GCC
EcoRI
MtTrxBFor CCC CCC CAT ATG GTG ACT ACC CGA GAC CTC ACT
GCC
NdeI
MtTrxBH6Rv CCC CCC GAA TTC TCA GTG ATG GTG ATG GTG ATG
GGC TTG TTG GGC TCG CCC GTT
EcoRI
MtH6TrxCFor CC CCC CCC CAT ATG CAT CAC CAT CAC CAT CAC ACC
GAT TCC GAG AAG TCC GCC
NdeI
MtTrxCRv CC CCC CCC AAG CTT CTA GTT GAG GTT GGG AAC CAC
GTC
HindIII
MtAhpDFor CC CCC CCC CAT ATG AGT ATA GAA AAG CTC AAG GCC
GCG
NdeI
MtAhpDRv CC CCC CCC AAG CTT TTA GCT TGG GCT TAG TGC CTC
GAT
HindIII
MtH6TPxFor CCC CCC CAT ATG CAT CAC CAT CAC CAT CAC GCA
CAG ATA ACC CTG CGA GGA
NdeI
MtTPxRv CCC CCC AAG CTT CTA GGC GCC CAG CGC GGC HindIII
2.3.12 Polymerase chain reaction (PCR)
The PCR was performed in a total volume of 50 µl with the PCR Master Mix
(ABgene, Hamburg, Germany). The composition of the PCR reaction is
listed in Table 2.7.
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Table 2.7: PCR reaction compositon
chromosomal DNA / plasmid DNA 0.5 – 1 µg / 10 – 500 ng
5’-primer, 3’-primer 0.5 µM of each
Thermoprime Plus DNA Polymerase 1.25 units
Tris-HCl (pH 8.8) 75 mM
(NH4)2SO4 20 mM
Tween 20 0.01 % (v/v)
dATP, dCTP, dGTP, dTTP 200 µM of each
MgCl2 1.5 mM
sterile de-ionized water to 50 µl total volume
The PCR reaction was carried out in a T3 Thermocycler (Biometra, Göttin-
gen, Germany) as follows:
denaturing: 2 min 96 ° C 1 cycle
denaturing: 1 min 96 ° C
annealing: 1 min TA
elongation: 3 min 72 ° C 30 cycles
elongation: 10 min 72 ° C 1 cycle
2.3.13 DNA sequencing
Automated non-radioactive sequencing of DNA was carried out according to
the di-deoxy-method of Sanger (Sanger et al., 1977). The ABI PRISM Dye
Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems,
Darmstadt, Germany) was used on a 373A Applied Biosystems DNA Se-
quencing System (Applied Biosystems, Darmstadt, Germany) according to
the manufacturers advice.
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2.4 Biochemical methods
2.4.1 SDS polyacrylamide gel electrophoresis (SDS-PAGE)
SDS polyacrylamide gels were used for determining the molecular weight of
the denatured proteins and to check the efficiency of recombinant protein
expression and purification. SDS-PAGE was performed with the Minigel
System (dimension of the gel: 11 cm x 7 cm x 0.1 cm; Biometra, Göttingen,
Germany) as described by Laemmli (1970). All samples were diluted 1:2
with 2-fold loading buffer (Table 2.8) and denatured at 95 ° C for 10 min.
Electrophoresis was performed at 60 V for the stacking gel and at 140 V for
the running gel.
Table 2.8: Solutions used for SDS-PAGE
2x SDS loading buffer SDS electrophoresis buffer
100 mM Tris-HCl pH 6.8 25 mM Tris-base
200 mM DTT 250 mM glycin
4 % (w/v) SDS 0.1 % (w/v) SDS
0.2 % (w/v) bromophenolblue
4x Upper Tris 4 x Lower Tris
0.5 M Tris-HCl pH 6.8 1.5 M Tris-HCl pH 8.8
0.4 % (w/v) SDS 0.4 % (w/v) SDS
stacking gel (4 %) running gel (15 %)
0.7 ml Rotiphorese Gel 30 (Roth,
Karlsruhe, Germany)
7.5 ml Rotiphorese Gel 30 (Roth,
Karlsruhe, Germany)
1.25 ml Upper Tris 3.8 ml Lower Tris
3 ml de-ionized H2O 3.6 ml de-ionized H2O
12 µl TEMED 18 µl TEMED
6 µl 40 % (w/v) APS 12 µl 40 % (w/v) APS
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2.4.2 Coomassie staining
SDS-PAGE gels were fixed for 30 min in a fixing solution (40 % (v/v) etha-
nol, 10 % (v/v) acetic acid and 50 % (v/v) de-ionized H2O). The Coomassie
staining solution (2 tablets PhastGel Blue R (Amersham Biosciences,
Freiburg, Germany) in 1 liter fixing solution) was prewarmed to 55 ° C – 60
° C, and the gels were stained for 30 min. After staining the gels were de-
stained with a mixture of 25 % (v/v) ethanol, 8 % (v/v) acetic acid and 67 %
(v/v) de-ionized H2O, using a de-stainer model 556 (BioRad, Munich, Ger-
many).
2.4.3 Determination of protein concentration
Protein concentrations were determined by the method of Bradford (1976)
using the BioRad Protein Assay (BioRad, Munich, Germany) and BSA (Bo-
vine Serum Albumin) as a standard, according to the manufacturers advice.
2.4.4 Ultra-filtration
Ultra-filtration is a convective process that uses anisotropic semi-permeable
membranes to separate macromolecular species and solvents primarily on
the basis of their size. It is particularly appropriate for the concentration of
macromolecules and has also been used for solvent exchange. For ultra-
filtration the Vivaspin centrifugal concentrators (Sartorius, Göttingen, Ger-
many) were used. The molecular weight cut off was chosen to correspond to
the molecular weight of the protein.
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2.4.5 N-terminal amino acid sequencing
The protein of interest was separated by SDS-PAGE (see 2.4.1), blotted
onto PVDF membrane (Immobilon P; Millipore, Schwalbach, Germany) for
30 min at 15 V using a Trans-Blot Semi-Dry Transfer Cell (BioRad, Munich,
Germany). The membrane was stained with Coomassie solution (see 2.4.2)
until the bands could be seen. The band of interest was cut out of the mem-
brane, washed in de-ionized H2O and used for sequencing. The N-terminal
amino acid sequencing was kindly performed on a protein sequencer 473A
(Applied Biosystems, Darmstadt, Germany) by Rita Getzlaff (GBF,
Braunschweig, Germany).
2.4.6 Matrix-assisted laser desorption and ionization time-of-flight
(MALDI-TOF) mass spectrometry
The molecular masses of the purified recombinant proteins were analyzed
by MALDI-TOF mass spectrometry at the GBF (Braunschweig, Germany)
using a Bruker Reflex  MALDI-TOF (Bruker, Bremen, Germany).
2.4.7 Isolation of mycothiol
Mycothiol (MSH) was isolated from Mycobacterium smegmatis. M. smegma-
tis
 cells were disrupted by boiling them for 10 min at 95 ° C in 10 mM Tris-
HCl at pH 8. MSH was isolated from the crude M. smegmatis soluble extract
essentially as described by Unson et al. (1998).
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2.5 Expression and purification of recombinant proteins
2.5.1 Creation of a Master Seed Bank
To standardize organism cultures and expression conditions a Master Seed
Bank (MSB) was set up for each expression strain. Bacterial stocks were
prepared from a single colony of each expression strain and stored at -80 ° C
in LB ( E. coli) or 7H9 (M. smegmatis) broth containing 50 % (v/v) glycerol.
2.5.2 Induced expression of recombinant proteins in E. coli
The open reading frames (ORF) of the genes of interest were cloned into the
pET22b(+) expression vector (Novagen, Madison, USA) under the control of
an IPTG inducible bacteriophage T7 RNA polymerase promoter. 100 ml
preculture (LB + 200 µg/ml ampicillin + 1 % (w/v) glucose) was inoculated
with 1 vial from the MSB and incubated overnight at 37 ° C with moderate
shaking. The main culture was inoculated with an OD600 of 0.1 and grown at
37 ° C until an OD 600 of 0.6 to 0.8 was reached. At that point expression was
induced with 0.5 mM IPTG and the incubation temperature was changed to
30 ° C. The LB medium was supplemented with glucose to maintain low
basal expression levels (Grossman et al., 1998). After up to overnight ex-
pression, cells were harvested by centrifugation (5000 x g, 15 min, 4 ° C) and
cell pellets were stored at -20 ° C until they were used for purification. Cell
cultivation and expression was either performed in Erlenmeyer flasks or in a
5-liter Biostat B Fermentor (B. Braun, Melsungen, Germany). All recombi-
nants overexpressed proteins, the corresponding E. coli strain and induction
times are listed in Table 2.9.
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Table 2.9: Overexpressed, recombinant proteins
rec. protein 6xHis-tag plasmid strain induction
time
MtRv2466c C-terminal pET22b(+) E. coli Tuner (DE3) 4 h
MtAhpC C-terminal pET22b(+) E. coli BL21 (DE3) overnight
MtAhpD non pET22b(+) E. coli Tuner (DE3) 4 h
MtTrxA C-terminal pET22b(+) E. coli Tuner (DE3) 5 h
MtTrxB C-terminal pET22b(+) E. coli Tuner (DE3) 5 h
MtTrxC N-terminal pET22b(+) E. coli Tuner (DE3) 5 h
MtTR N-terminal pTrcHis A E. coli Tuner (DE3) 5 h
MtTPx N-terminal pET22b(+) E. coli Tuner (DE3) 5 h
2.5.3 Induced expression of MtMycR in M. smegmatis
The MycR ORF was cloned with a C-terminal His-tag into the pMV261 vec-
tor under the control of the mycobacterial HSP60 promoter. 150 ml precul-
ture (7H9 + 50 µg/ml kanamycin) of the recombinant M. smegmatis was in-
oculated with 1 vial from the MSB and incubated for 48 h at 37 ° C with
moderate shaking. The main culture was inoculated with an OD600 of 0.4 and
grown at 30 ° C until an OD 600 of 1.0 was reached. At that point expression
was induced by heat shock at 45 ° C. At an OD 600 of 2 the cells were har-
vested by centrifugation (7000 x g, 30 min, 4 ° C) and cell pellets were stored
at -20 ° C until they were used for purification. Cultivation and expression of
the recombinant mycobacterial strain was performed in a 5-liter Biostat B
Fermentor (B. Braun, Melsungen, Germany).
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2.5.4 Cell disruption by sonication
The pelleted cells were re-supended in 1/10 of the suitable buffer for purifi-
cation or other means. The cell suspension was cooled on ice and sonicated
for 1 min with a Sonoplus Ultrasonic Homogenizer HD 2200 (Bandelin, Ber-
lin, Germany). For volumes more than 10 ml the sonication step was re-
peated 3 times. After the cell disruption the crude extracts were centrifuged
at 25000 x g, 4 ° C for 30 min. The supernatant, containing the soluble
proteins, was used for purification or for other purposes.
2.5.5 Chromatographic methods
The BioLogic Workstation or the BioLogic DuoFlow System (BioRad, Mu-
nich, Germany) was used for all chromatographic applications.
2.5.5.1 Nickel chelate chromatography
For the purification of 6xHis-tagged recombinant proteins the Ni-NTA Super-
flow resin (Qiagen, Hilden, Germany) was used. This resin allows one-step
purification of 6xHis-tagged proteins using high flow rates and pressures for
efficient FPLC applications. The capacity for 6xHis-tagged proteins is 5 – 10
mg/ml. Purification buffers and methods were carried out essentially ac-
cording to the QIAexpressionist Handbook (5th edition; Qiagen, Hilden, Ger-
many). Cells were sonicated in 50 mM NaH2PO4, 300 mM NaCl, 10 mM imi-
dazole at pH 8 (binding buffer) and the soluble extract was applied to the
column. The column was washed with 5-bed volumes of binding buffer and
finally eluted with a linear gradient from 0 % to 100 % elution buffer (binding
buffer with 500 mM imidazole). The imidazole concentrations at which the
different heterologously expressed proteins eluted, are listed in Table 2.10.
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Table 2.10: Imidazole concentration for elution of the recombinant proteins
recombinant protein imidazole concentration for elution
MtRv2466c 120 mM
MtMycR 100 mM
MtAhpC 190 mM
MtTrxA 150mM
MtTrxB 125 mM
MtTrxC 100 mM
MtTR 110 mM
MtTPx 180 mM
2.5.5.2 Anion exchange chromatography
An UNOsphere Q column (BioRad, Munich, Germany) was used for anion
exchange chromatography according to the manufacturers instruction man-
ual. UNOsphere Q is an high-capacity, high-throughput anion exchange
capture support, based on acrylamide and vinylic monomers, designed for
process chromatography. The column was equilibrated with 10 bed volumes
20 mM Tris-HCl at pH 7.4. The sample was loaded onto the column, which
was then washed with 5 bed volumes of the equilibration buffer. The proteins
were eluted by a linear gradient of 0 % to 100 % 20 mM Tris-HCl, 1 M NaCl
at pH 7.4.
2.5.5.3 Hydrophobic interaction chromatography (HIC)
For hydrophobic interaction chromatography, a HiLoad 16/10 Phenyl Sepha-
rose High Performance column (Amersham Biosciences, Freiburg, Ger-
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many) was used according to the manufacturers advice. HIC separates pro-
teins and peptides on the basis of their varying strength of interaction with
hydrophobic groups attached to an uncharged gel matrix. The column was
equilibrated with 20 mM Tris-HCl, 1 M (NH4)2SO4 at pH 7.4. The protein so-
lution was diluted with 20 mM Tris-HCl, 2 M (NH4)2SO4 at pH 7.4 till the final
concentration of (NH4)2SO4 reached 1 M. The sample was loaded onto the
column, which was then washed with 5 bed volumes of the equilibration
buffer. The elution was performed by linearly decreasing the concentration of
(NH4)2SO4. The recombinant expressed mycobacterial AhpD eluted at 400
mM (NH4)2SO4.
2.5.5.4 Gel permeation
Sephadex G-25 (Amersham Biosciences, Freiburg, Germany) was used for
desalting and for the buffer exchange of larger volumes of protein solutions.
Sephadex is a bead-formed gel. Gel filtration separates molecules according
to their relative sizes. Large molecules are totally excluded while smaller
sized molecules enter the beads to varying extents according to their sizes.
Large molecules thus leave the column first followed by smaller molecules in
the order of their decreasing size.
2.5.6 Estimation of the molecular size of native proteins
Reduced MtAhpC was chromatographed on a Superdex 200 HR 10/30 col-
umn (Pharmacia, Freiburg, Germany) using a mixture of 10 mM sodium
phosphate buffer and 20 mM DTT at pH 7.6 as the eluent. High molecular
weight standards (Pharmacia, Freiburg, Germany) were used for column
calibration. Eluted peroxidase was identified by activity measurements and
SDS-PAGE. For size determination of oxidized MtAhpC, the enzyme was
incubated with 300 µM t-bOOH at room temperature for 30 min in 10 mM
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sodium phosphate buffer at pH 7.6. The molecular weight was then esti-
mated by gel permeation chromatography as described above. Gel permea-
tion analyses of reduced and oxidized MtAhpD and MtTPx were performed
essentially as described for MtAhpC, using a Superdex 75 HR 10/30 column
(Pharmacia, Freiburg, Germany) and low molecular weight standards
(Pharmacia, Freiburg, Germany) for column calibration.
2.6 Electron microscopy studies
The electron microscopy studies were kindly facilitated by Heinrich Lünsdorf
and Elke Barth (GBF, Braunschweig, Germany). After gel permeation the
reduced or oxidized MtAhpC (60 µg/ml final concentration) was adsorbed to
an ultrathin carbon foil for 30 s at ambient temperature and was negatively
stained immediately in 4 % (w/v) uranyl acetate at pH 4.5, according to Val-
entine et al. (1968). The carbon foil was picked up with perforated collodion
microgrids, prepared according to Lünsdorf and Spiess (1986), blotted with
filter paper and air-dried. Samples were analyzed with an energy-filtered
transmission electron microscope (EFTEM) CEM 902 (Zeiss, Oberkochen,
Germany) in the elastic bright-field imaging mode (spectrometer slit: 30 eV;
objective aperture: 30 µm; condenser aperture: 300 µm) at 85,000 primary
magnification close to the Scherzer focus. Images were directly registered
with a cooled 1024 x 1024 CCD-camera (Proscan, Scheuring, Germany) and
digitally optimized for sharpness and contrast with Corel Photopaint com-
puter software (Corel Corporation, Ottawa, Canada).
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2.7 Enzymatic assays
2.7.1 Insulin reduction assay
Interaction of thioredoxin-like proteins with thioredoxin reductase (TR) was
tested through the insulin reduction assay as described by Luthman and
Holmgren (1982). In the insulin reduction assay, the rate of conversion of
NADPH to NADP+ is measured by the decrease in A340. In this process, re-
duction equivalents are transferred from NADPH to thioredoxin (Trx) via TR.
The reduced form of Trx in turn reduces insulin, thereby separating the A
and B chains. The test system contained 13.5 µM MtTR, variable concentra-
tions of Trx-like proteins (MtTrxA, MtTrxB, MtTrxC, MtAhpD or Rv2466c; 0.7
µM to 10 µM), 200 µM bovine insulin (Sigma, Taufenkirchen, Germany), 400
µM NADPH in 50 mM HEPES, 2 mM EDTA at pH 7.4 in a total volume of
500 µl. The decrease in A340 was monitored over time, and the amount of
NADPH oxidized was calculated with a molar extinction coefficient of 6296
M-1cm-1.
2.7.2 MycR assay
The activity of MtAhpC with MSH and MtMycR was tested at 25 ° C in a
system that contained 450 µM NADH or NADPH, 0.2 µM – 20 µM MtMycR,
0.2 µM – 20 µM MSH, 0.2 µM – 20 µM MtAhpC, 73 µM t-bOOH in 50 mM
HEPES, 1 mM EDTA at pH 7.4 in a final volume of 500 µl. The decrease in
A340 was monitored over time.
2.7.3 AhpD assay
The specific activity of MtAhpC with MtAhpD was quantified by measuring
the initial velocities through monitoring the NADH oxidation at 340 nm at 25
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° C. The test system contained 450 µM NADH, 200 nM MtAhpD, 0.4 U bo-
vine lipoamide dehydrogenase (Sigma, Taufenkirchen, Germany), 50 µM
lipoamide, 0.5 µM – 10 µM MtAhpC, 73 µM t-bOOH in 50 mM HEPES, 1
mM EDTA at pH 7.4 in a final volume of 500 µl. The reaction was preincu-
bated for 15 min at 25 ° C and started by the addition of peroxide. For the
AhpD-dependent kinetic studies of MtAhpC, the conditions were nearly the
same as for the measurement of the acitivity using 5 µM MtAhpC and fixed
MtAhpD concentrations. A range between 5 µM – 65 µM t-bOOH was used
for the calculation of the kinetic pattern.
2.7.4 AhpC and TPx assay
The specific activities of MtAhpC with MtTrxC  and MtTPx with MtTrxB or
MtTrxC were obtained by measuring initial velocities monitoring the NADPH
oxidation at 340 nm at 25 ° C. The test system contained 450 µM NADPH, 10
µM MtTR, 10 µM MtTrxB or MtTrxC, 0.5 µM – 15 µM MtAhpC or 0.2 µM – 5
µM MtTPx, 100 nM bovine catalase (Roche, Mannheim, Germany), 73 µM t-
bOOH in 50 mM HEPES, 1 mM EDTA at pH 7.4 in a final volume of 500 µl.
The reaction was preincubated for 15 min at 25 ° C and started by the addi-
tion of peroxide. For the kinetic studies of MtAhpC and MtTPx the conditions
were nearly the same as for the measurement of the activities using 5 µM of
the peroxidase and fixed thioredoxin concentrations. A range between 5 µM
– 65 µM t-bOOH was used for the calculation of the kinetic pattern. Specific-
ity for H2O2, cumene hydroperoxide, linoleic acid hydroperoxide and phos-
phatidylcholin hydroperoxide were investigated accordingly. The last two
were prepared from soybean lipoxygenase-catalyzed oxidation of the corre-
sponding lipids and were kindly provided by R. Brigelius-Flohé (German In-
stitute of Human Nutrition, Potsdam, Germany).
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2.7.5 Steady-state kinetics
Substrate turnover by peroxidases was monitored continuously by NAD(P)H
consumption in a coupled test system. The data was analyzed according to
Dalziel (1957). Results are presented in terms of the general Dalziel-
equation for two substrate reactions:
                                     (1)
Where, [E0] is the total enzyme concentration, v is the initial velocity at perti-
nent substrate concentrations, and φ0, φ1, φ2, and φ1,2 are kinetic coefficients
characterizing a particular enzyme. With enzyme mechanisms not involving
ternary complexes between the enzyme and both substrates, the term
φ1,2/[A] [B] is zero. In such “ping-pong” or enzyme substitution mechanisms
the rate equation simplified to
                                                 (2)
Accordingly, re-plotting of the ordinate intercepts, i.e., the reciprocal en-
zyme-normalized apparent maximum velocities for infinite concentrations of
t-bOOH (= [A]) against the reciprocal concentrations of the corresponding
reductant (= [B]) yields φ0 as ordinate intercepts and φ2 being the slope. φ0 is
defined as the reciprocal value of the velocity at infinite concentration of both
substrates, that means of kcat. The reciprocal net forward rate constant k′1,
which describes the oxidation of reduced enzyme by ROOH, by definition,
equals φ1. φ2 describes a reductant-dependent step, thus must be the recip-
rocal k′2.
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2.7.6 Stopped-flow kinetics
The stopped-flow analyses were kindly performed by Rafael Radi and Madia
Trujillo (Departamento de Bioquímica, Facultad de Medicina, Universidad de
la República, Montevideo, Uruguay).
2.7.6.1 Direct measurement of peroxynitrite reduction by MtTPx by
stopped-flow technique
MtTPx was reduced by overnight treatment with 10 mM DTT at 4 ° C. Excess
reductant was removed immediately before use by gel filtration on Hitrap
columns (Amersham Biosciences) using degased 100 mM sodium phos-
phate buffer, 0.1 mM DPTA (diethylene-triamine-pentaacetic acid) at pH 7
as the eluent, followed by extensive bubbling with argon. Peroxynitrite was
synthesized in a quenched flow reactor as described previously (Radi et al.,
1991; Beckman et al., 1994), and excess hydrogen peroxide was removed
by treatment with MnO2. Peroxynitrite concentration was determined spec-
trophotometrically by the measurement of its absorption at 302 nm in 1 M
NaOH (ε302 = 1670 M-1cm-1). The kinetics of peroxynitrite reaction with re-
duced MtTPx was studied at 302 nm in a stopped-flow spectrophotometer
(SX-17MV, Applied Photophysics) with a mixing time of less than 2 ms, fol-
lowing peroxynitrite decomposition in the presence and absence of the en-
zyme. To ensure the accuracy of the rate constant determinations, 200 ab-
sorbance measurement points were acquired during the initial part of the
reaction (first 50 ms) and 200 additional points were acquired until more
than 90 % of the peroxynitrite had decomposed (0.5 ms – 20 ms). Computer
assisted simulations were performed using Gepasi software (Mendes,
1997). With this experimental approach peroxynitrite can either react with
the reduced enzyme to yield the oxidized enzyme and nitrite or it can de-
2 - MATERIALS AND METHODS 39
compose to nitrate after a proton-catalyzed isomerization (k = 0.26 s-1 at pH
7.4 and 25 ° C; Koppenol et al., 1992).
ONOOH → NO3− + H+                                                                                  (3)
ONOOH + MtTPx red → NO2− + MtTPx ox                                                     (4)
The apparent second order rate constant for the reaction of the enzyme and
peroxynitrite at pH 7.4 and 37 ° C was varied in order to get the best fit to
experimental data.
2.7.6.2 Rate constant determination of peroxynitrite reduction by com-
petition experiments
Mn3+ porphyrins are rapidly oxidized by peroxynitrite (k = 105 – 107 M-1s-1 at
pH 7.4 and 37 ° C) to O=Mn4+ which can be conveniently monitored at the
Soret band (Ferrer-Sueta et al., 2003). The inhibitory effect of MtTPx on the
oxidation of Mn3+-meso-tetrakis[(N-ethyl)pyridinium-2-yl]porphyrin (Mn3+-TE-
2-PyP) by peroxynitrite was determined by stopped-flow techniques, since
Mn4+ is an unstable species that is readily reduced back to Mn3+, presumably
by nitrite (Ferrer-Sueta et al., 1999). Mn3+-TE-2-PyP oxidation by peroxyni-
trite was monitored at different MtTPx concentrations. Experiments were
performed at 25 ° C and the pH was measured at the outlet.
Percentage inhibition of peroxynitrite-dependent Mn3+-TE-2-PyP oxidation by
MtTPx can be fitted to a hyperbolic function of the type y = ax/(b+x), where
“a” corresponds to the percentage of initial Mn3+-porphyrin oxidation by per-
oxynitrite (in the absence of competing enzyme) and “b” corresponds to the
concentration of enzyme that half-inhibits peroxynitrite-dependent Mn3+-
porphyrin oxidation. From this plot a “b” value of 5.7 µM was obtained. At
that point kMtTPx[MtTPx] equals kMn3+[Mn3+], which allows the calculation of k1
for the reaction of the peroxidase with peroxynitrite (kMtTPx).
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2.8 Molecular modeling
The molecular modeling was kindly done by Birgit Hofmann (GBF,
Braunschweig, Germany). Structure models of MtTPx were generated using
Bragi (Schomburg and Reichelt, 1988) and sequence alignments of Clustalx
(Thompson et al., 1997). The model of the MtTPx was based on the struc-
ture of Crithidia fasciculata tryparedoxin peroxidase (TXNPx) (Hofmann et
al., 2001) and other peroxiredoxins (Hirotsu et al., 1999; Schroeder et al.,
2000). The model of the TPx/Trx intermediate was generated from the model
of oxidized C. fasciculata TXNPx (Hofmann et al., 2001) and the structure of
E. coli
 Trx  using O (Jones et al., 1991). Initially, the model of oxidized
MtTPx alone was refined (Amber6, University of California at San Francisco,
www.amber.ucsf.edu/amber/indexs.html) by energy minimization to release
strain introduced by sequence exchange. The protein complex was con-
structed from those refined MtTPx coordinates. Those of MtTrxC were re-
strained by the introduction of a disulfide bond between C34 of MtTrxC and
C93 of MtTPx, and refined by energy minimization, a 50 ps molecular dy-
namics simulation and a final energy minimization. Calculations were carried
out using an 8 
*
 water shell around the protein molecules.
2.9 Computer analyses
For DNA sequence analysis, alignments, primer design and primer analysis
the Vector NTI 6.0 program (InforMax Inc., Oxford, UK) was used. Micro-
grafx Designer 4.1 (Corel Corporation, Ottawa, Canada) was used for crea-
tion of figures and schemes. Kinetics data were analyzed by Sigma Plot 8.0
(SPSS Inc., Chicago, USA). Database searches were performed using the
NCBI (http://www.ncbi.nlm.nih.gov) and TubercuList (http://genolist.past-
eur.fr/TubercuList) databases.
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3 Results
3.1 Preparation of system components
The M. tuberculosis genome (Cole et al., 1998) was screened for homo-
logues of AhpF, thioredoxin-related proteins and peroxiredoxins. For the re-
constitution of different peroxidase systems the components were prepared
as follows:
The MtMycR ORF (Rv2855) was amplified from M. tuberculosis genomic
DNA by PCR with the primers MtMycRFor and MtMycRH6Rv. The PCR
product was cloned into the mycobacterial expression vector pMV261, di-
gested with corresponding set of restriction enzymes. Protein expression
was induced in M. smegmatis by heat shock (45 ° C) and the soluble protein
was purified by nickel chelate chromatography.
The AhpD ORF (Rv2429) was amplified by PCR using the primers
MtAhpDFor and MtAhpDRv and cloned into the procaryotic expression vec-
tor pET22b(+) digested with corresponding set of enzymes. Expression was
induced in E. coli Tuner (DE3) with 0.5 mM IPTG at 30 ° C. The hetero-
logously expressed protein was primarily found in the soluble extract.
MtAhpD was purified to homogeneity by anion exchange chromatography
and hydrophobic interaction chromatography.
The AhpC (Rv2428), TrxA (Rv1470), TrxB (Rv1471), TrxC (Rv3914),
Rv2466c and TPx (Rv1932) ORFs were amplified by PCR using the corre-
sponding primers listed in Table 2.6. The PCR products were cloned into
pET22b(+) and expression was induced in E. coli Tuner (DE3) or BL21
(DE3) with 0.5 mM IPTG at 30 ° C (induction times are listed in Table 2.9).
All proteins were primarily found in the soluble extract. Purification to homo-
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geneity of the His-tagged proteins (TrxA, TrxB, TrxC, AhpC, Rv2466c and
TPx) was achieved by nickel chelate chromatography (for example see Fig.
3.1).
The correctness of the sequence was verified by DNA sequencing and the
identities of the proteins were confirmed by MALDI-TOF analysis and N-
terminal Edman degradation.
Fig. 3.1: Purification of MtTrxA, B and C using nickel chelate chromatography. SDS-
PAGE followed by Coomassie blue staining. Lane 1, crude extract of recombinant E. coli
Tuner (DE3) [pET22b(+)/MtTrxA] 4 hours after induction; lane 2, purified MtTrxA; lane 3,
crude extract of recombinant E. coli Tuner (DE3) [pET22b(+)/MtTrxB] 4 hours after in-
duction; lane 4, purified MtTrxB; lane 5, crude extract of recombinant E. coli Tuner (DE3)
[pET22b(+)/MtTrxC] before induction (control); lane 6, purified MtTrxC; M, protein mo-
lecular weight markers. Molecular masses (in kilodaltons) are indicated to the left of the
gel.
3.2 Peroxide detoxification pathways
3.2.1 Attempt to reconstitute a mycothiol reductase system
Although attempts to substitute the missing AhpF by homologous mycothiol
reductase (MtMycR) and mycothiol (MSH) for alkyl hydroperoxide reductase
(MtAhpC) reduction have failed so far (Vergauwen et al., 2001), a reconsti-
tution of that system was tried for verification. It was confirmed that MtMycR
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does not reduce MtAhpC. Neither did MSH even if kept in its thiol form by
NAD(P)H and MtMycR efficiently reduce MtAhpC (see 2.7.2). The potential
function of MtMycR and MSH, a small molecular weight thiol proposed to
substitute the missing glutathione in mycobacteria, remains elusive. The un-
successful attempt to reduce MtAhpC rules out its function as MtAhpC re-
ductant.
3.2.2 Reconstitution of the AhpD-dependent AhpC system
It was also confirmed that MtAhpD is reduced by lipoamide and can in turn
reduce MtAhpC, as described by Bryk et al. (2002). Lipoamide, kept reduced
by NADH and, for convenience, by bovine lipoamide reductase, together
with MtAhpD and MtAhpC constitute a peroxidase system.
3.2.3 A novel thioredoxin-dependent AhpC system
Intrigued by the recent observation that Helicobacter pylori, which like M.
tuberculosis
 lacks AhpF, uses thioredoxin for AhpC reduction (Baker et al.,
2001), attempt was made to reconstitute mycobacterial peroxidase systems
by combining AhpC with thioredoxin reductase (MtTR) and various CXXC-
containing proteins (Fig. 3.2).
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Fig. 3.2: Alignment of thioredoxin A, B and C and amino acid sequences of AhpD
and Rv2466c from M. tuberculosis. Conserved residues are shown in red, **** indicate
the CXXC motifs.
MtTR, which also is homologous to AhpF, did not reduce MtAhpD. MtTR did
neither reduce MtTrxA nor the glutaredoxin-related Rv2466c protein but only
the MtTrxB and C, as was shown in the insulin reduction assay described by
Holmgren and Luthman (1982). TrxB and C were shown to have similar ac-
tivities, although the redox activity of TrxC was somewhat higher than TrxB
(Fig. 3.3). Thus, M. tuberculosis has at least two functionally active thiore-
1                                             48
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doxins that may protect the pathogen against oxidants derived from the
macrophage.
Fig. 3.3: Results of the insulin reduction assay (see 2.7.1). MtTR was used in a con-
centration of 13.5 µM in combination with variable concentrations of MtTrxB or MtTrxC
(0.7 to 4.6 µM) in a total volume of 500 µl. The decrease in A340 was monitored over time,
and the amount of oxidized NADPH was calculated with a molar extinction coefficient of
6296 M-1cm-1.
Surprisingly, MtTrxC efficiently reduced MtAhpC, while MtTrxB did not. Hil-
las et al. (2000) reported that thioredoxin and thioredoxin reductase are not
the native partners for MtAhpC and MtAhpD. An explanation for the deviation
from the results reported here could be that they did not use TrxC or they
could not measure activity due to spontaneous NADPH consumption. When
that peroxidase system was reconstituted, the system components led to an
unspecific NADPH consumption without the addition of peroxide. H2O2 pro-
duction by autoxidation of reduced MtTR was considered to cause that com-
plication. Indeed there was no NADPH consumption observed after addition
of catalase. In further experiments, based on the TR/Trx system, catalase
was added to the test systems and the activity was measured with an or-
ganic hydroperoxide which is not a substrate of catalase.
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3.2.4 Another novel thiol peroxidase system
MtTrxC also reduced another mycobacterial peroxiredoxin (Rv1932) that, by
sequence homology, had been classified as a “thiol peroxidase” (TPx) but
had never been investigated in regards to its activity and specificity. While
studying proteome information on M. tuberculosis (Mollenkopf et al., 1999)
we noticed that Rv1932 (TPx) was present as a dominant spot in 2-D gels.
Homologues of TPx are distributed throughout most or all eubacterial spe-
cies, both Gram-negative and Gram-positive, and are found in pathogenic
strains such as Helicobacter pylori (Wan et al., 1997), but biochemical and
genetic analyses have been limited primarily to E. coli TPx (EcTPx). In re-
sponse to oxidative stress, E. coli up-regulates TPx expression (Cha et al.,
1995; Kim et al., 1996; Kim et al., 1999), and tpx deletion mutants, while still
viable, were more susceptible to oxidative stress and displayed diminished
colony sizes and numbers after exposure to peroxide (Cha et al., 1996).
EcTPx forms a Trx-linked peroxidase system capable of reducing H2O2 and
ROOH and protecting against glutamine synthetase inactivation by a mixed
function oxidation system (Cha et al., 1995; Baker and Poole, 2003).
MtTPx not only accepted MtTrxC, but also MtTrxB although with a slightly
lower affinity and reactivity (Table 3.1). MtTPx belongs to a subfamily of 2-
Cys-peroxiredoxins which, in contrast to AhpC and other 2-Cys-
peroxiredoxins, are considered to be functionally monomeric. Their mecha-
nism of action is believed to involve oxidation of an N-proximal cysteine
residue, here Cys-60, to a sulfenic acid derivative by the hydroperoxide sub-
strate. That is followed by formation of an intramolecular disulfide bridge
with a distal cysteine, here Cys-94 (see Fig. 4.1). In comparison, in the oli-
gomeric 2-Cys-peroxiredoxins the corresponding reaction center is built up
between two subunits (Hofmann et al., 2002; Wood et al., 2003a; Baker and
Poole, 2003).
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3.3 Kinetics and particularities
For the characterization and classification of the peroxidase systems dis-
covered in this study, the different systems were analyzed by steady-state
kinetics. The kinetic behaviour of the analyzed peroxiredoxins (MtAhpC and
MtTPx) was only investigated with the most convenient substrate, t-butyl hy-
droperoxide. As an additional measure of precaution, sufficiently high en-
zyme concentration was chosen to allow completion of the reaction within
less than 10 min. Initial velocities were read from the substrate consumption
curves that correspond for up to 13 residual substrate concentrations giving
equidistant abscissa points in the double reciprocal plot (primary plot).
Thereby, a balanced and unbiased statistical weight of the individual veloci-
ties over the substrate range between 95 % and 3 % of the starting concen-
tration was guaranteed. Three data sets were thus generated. The slopes of
the regression lines and the ordinate intercepts of three to five independent
experiments were averaged and used for the generation of secondary plots
to obtain kinetic coefficients and constants (see 2.7.5).
3.3.1 The AhpD-dependent AhpC system
For comparison of the different enzyme systems discovered in this thesis,
the MtAhpD/MtAhpC system was analyzed at steady-state kinetics, eluci-
dated here for the first time. The time progression curves were unusual,
starting with a lag phase when the fully reduced system was started with t-
butyl hydroperoxide (t-bOOH) as MtAhpC substrate (Fig. 3.4, trace A; ar-
row). Reversible inhibition by the initially high hydroperoxide concentration
does not account for the phenomenon, since it is observed identically from
20 µM up to 73 µM initial [t-bOOH]. Surprisingly, the reaction started at
maximum rate if MtAhpC and MtAhpD were preincubated with t-bOOH for 2
min (Fig. 3.4, trace B) indicating a facilitated interaction of the reactant pairs.
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Fig. 3.4: Oxidative activation of the MtAhpC/MtAhpD system by t-bOOH. MtAhpC
activity with MtAhpD as cosubstrate was tested in a coupled test system where MtAhpD
oxidation is continuously monitored by lipoamide/lipoamide dehydrogenase-mediated
NADH consumption. Trace A: The reaction mixture was preincubated for 15 min at 25 ° C
under reductive conditions and started by the addition of t-bOOH ( + ). Trace B: The re-
action mixture except MtAhpC, MtAhpD and t-bOOH was preincubated for 15 min at 25
° C. MtAhpC, MtAhpD and the hydroperoxide were preincubated together for 2 min at 25
° C and the reaction was started by the addition of this mixture (
+
). Notice the delayed
onset of NADH consumption in trace A (arrow).
Redox-dependent conformational changes might improve the accessibility of
the reaction centers or transfer the participating proteins into an activated
form. Therefore the oligomerization states of MtAhpD and MtAhpC were
analyzed.
The X-ray structure of AhpD shows that the protein builds up a trimer in a
symmetrical cloverleaf arrangement. Each subunit exhibits a new all-helical
protein fold in which the two catalytic sulfhydryl groups, Cys-130 and Cys-
133, are located near a central cavity in the trimer (Nunn et al., 2002; Bryk et
al., 2002). AhpC of S. typhimurium tends to form decamers depending on its
redox status (Wood et al., 2002). For investigating the impact of the redox
state on the oligomerization, the unmodified MtAhpC was reduced by DTT or
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oxidized by t-bOOH and subjected to gel permeation on a calibrated Super-
dex 200 column. The effluents were investigated for their: (a) activity by the
conventional assay, (b) identity by SDS-PAGE, and (c) shape by electron
microscopy (Fig. 3.5 and Fig. 3.6). Reoxidation of the reduced MtAhpC was
prevented by equilibrating the column with 20 mM DTT. The reduced protein
eluted as a seemingly homogeneous peak with E280 paralleling its activity.
The eluting material was indistinguishable from authentic MtAhpC in reduced
SDS gels displaying a major band complying with the subunit size. Electron
micrographs, however, showed a very heterogeneous mixture of ring-
shaped, pearl-chain-like, and pearl-like structures (Fig. 3.5 B). The peak
fraction eluted with an apparent molecular weight of 224 kDa, which is con-
sistent with the decameric size. The ring structures are considered to repre-
sent the pentamers of dimers that were also reported for the AhpC of S. ty-
phimurium
 (Wood et al., 2002), and the homologous tryparedoxin peroxi-
dases (TXNPx) of Leishmania infantum (Castro et al., 2002) and Trypano-
soma brucei
 (Budde et al., 2003). The “pearls” and open chain structures
likely represent the dissociating decamers due to reoxidation after gel filtra-
tion.
The oxidized enzyme (Fig. 3.6) eluted with a main peak that was similar to
the molecular weight of a dimeric protein. Electron microscopy revealed that
the main peak consisted of homogeneous dimeric proteins.
For MtAhpD, gel permeation analyses pointed to a trimeric form independent
of the redox state (data not shown). Therefore, redox-dependent conforma-
tional changes might determine the accessibility of the reaction centers.
For convenience, steady-state analysis was performed without preincubation
of MtAhpC and MtAhpD (see 2.7.5). Lipoamide was not oxidized by t-bOOH
alone: the reaction required the addition of both MtAhpD and MtAhpC. None
of the components led to a non-specific NADH consumption. In consequence
of the previously mentioned oxidative activation the primary Dalziel plot that
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shows the reciprocal hydroperoxide concentration at different fixed MtTrxC
concentrations (Fig. 3.7 A) does neither yield constant slopes nor are the
slopes measured at different cosubstrate concentrations running in parallel.
The apparently ‘activated’ parts of the turnover curves for MtAhpC yielded a
net forward rate constant k′1, of 1 x 104 M-1s-1 for the reaction with t-bOOH,
which marks the lower edge of corresponding peroxiredoxin constants
(Hofmann et al., 2002; Wood et al., 2003a) In that context, a k′2 for the re-
duction by MtAhpD of 2.7 x 106 M-1s-1 which, like the KM MtAhpD of 0.23 µM,
argues in favour of specific reactivity (Fig. 3.7; Table 3.1).
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Fig. 3.5: Oligomerization status of reduced MtAhpC. (A) Elution profile of DTT-
reduced MtAhpC in terms of protein content (E280, solid line) and activity (U/ml, −•−). (B)
Appearance of the peak fraction in electron microscopy (uranylacetate-stained). Arrows
indicate ring-shaped and pearl-chain like structures.
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Fig. 3.6: Oligomerization status of oxidized MtAhpC. (A) Elution profile of t-bOOH-
oxidized MtAhpC in terms of protein content (E280, solid line) and activity (U/ml, −•−). (B)
Appearance of the peak fraction in electron microscopy (uranylacetate-stained).
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Fig. 3.7: Steady-state-kinetic analysis of MtAhpC with MtAhpD as cosubstrate. Sub-
strate turnover by MtAhpC was monitored continuously by NADH consumption in a cou-
pled test system at 25 ° C and pH 7.4 with t-butyl hydroperoxide (t-bOOH) as substrate
and MtAhpD as cosubstrate. Three sets of data were analyzed according to Dalziel
(1957). Results are presented in terms of the general Dalziel-equation for a two-
substrate reaction ([E0]/v = φ0 + φ1/[ROOH] + φ2/[reductant]; see Table 3.1). (A) Example
of primary Dalziel plot showing enzyme-normalized inverse initial velocities ([Eo]/v) de-
pendent on the reciprocal hydroperoxide concentration at different MtAhpD concentra-
tions, kept constant by continuous regeneration. The slopes correspond to φ1. (B) Sec-
ondary Dalziel plot: The ordinate intercepts of (A), i. e. the apparent maximum velocities
at [A] = ∞, are plotted against 1/[MtAhpD] for evaluation of Dalziel coefficient φ2 (slope),
limiting KM MtAhpD (abscissa intercept is 1/KM MtAhpD) and real maximum velocities (ordinate
intercept is φ0 = [E0]/Vmax). Primary data of three independent analyses, as shown in (A),
were used to obtain means and standard deviations.
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3.3.2 The thioredoxin-dependent AhpC system
The kinetic analysis of MtAhpC in the system reconstituted by homologous
TR and TrxC  surprised with irregularities similar to those that had previously
been observed with a TXNPx of L. infantum (Castro et al., 2002) and T. bru-
cei
 (Budde et al., 2003), and with the MtTPx in this study. Instead of a typical
ping-pong pattern that could be expected from the type of catalysis
(Hofmann et al., 2002) the primary Dalziel plot does neither yield constant
slopes nor appear the slopes measured at different cosubstrate concentra-
tions strictly parallel. In the cases of TXNPx of L. infantum and T. brucei this
kinetic anomaly was interpreted as being indicative of negative cooperativity
between subunits. The gel permeation analyses and electron micrographs of
reduced MtAhpC (see 3.2.2) yielded an average size of 224 kDa that under-
scores its decameric nature. The kinetic anomalies of MtAhpC could thus be
due to allosteric phenomena as are inferred for other oligomeric peroxire-
doxins.
The apparently flatter parts of the turnover curves yielded a k′1 of 2.3 x 104
M-1s-1 that is nearly identical to that obtained in the AhpD system, as was
expected from the ping-pong-type kinetics of AhpC (Fig. 3.8). Both the k′2
and the KM characterizing the reactivity and/or affinity to TrxC compare unfa-
vourately with the constants for AhpD by a factor 10 and 20, respectively, as
does the kcat (Table 3.1). Yet the relative cellular abundancies of the poten-
tial AhpC reductants (see 4.4) qualify MtTrxC as relevant one.
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Fig. 3.8: Steady-state-kinetic analysis of MtAhpC with MtTrxC as cosubstrate. Sub-
strate turnover by MtAhpC was monitored continuously by NADPH consumption in a
coupled test system at 25 ° C and pH 7.4 with t-bOOH as substrate and MtTrxC as co-
substrate. Three sets of data were analyzed according to Dalziel (1957). Results are
presented in terms of the general Dalziel-equation for a two-substrate reaction ([Eo]/v =
φ0 + φ1/[ROOH] + φ2/[reductant]; see Table 3.1). (A) Example of primary Dalziel plot
showing enzyme-normalized inverse initial velocities ([E0]/v) dependent on the reciprocal
hydroperoxide concentration at different MtTrxC concentrations, kept constant by con-
tinuous regeneration. The slopes correspond to φ1. Note the biphasic slopes; only the
flatter parts were used for data processing. (B) Secondary Dalziel plot: The ordinate in-
tercepts of (A), i. e. the apparent maximum velocities at [A] = ∞, are plotted against
1/[MtTrxC] for evaluation of Dalziel coefficient φ2 (slope), limiting KM MtTrxC (abscissa inter-
cept is 1/KM MtTrxC) and real maximum velocities (ordinate intercept is φ0 = [E0]/Vmax). Pri-
mary data of three independent analyses, as shown in (A), were used to obtain means
and standard deviations.
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3.3.3 The thiol peroxidase systems
Steady-state kinetics of MtTPx activity with t-butyl hydroperoxide and
MtTrxB as substrates (Fig. 3.9) display a classical ping-pong pattern, which
can be depicted as a sequence of consecutive reactions,
Trxred + TPxox ↔ Trxox + TPxred                                                                    (5)
TPxred + ROOH → TPxox + ROH + H2O                                                       (6)
where ROH is the corresponding alcohol. These redox reactions are typi-
cally observed with peroxidases.
With MtTrxC as substrate, however, the slopes in reciprocal primary plots
(Fig. 3.10) appear not to be strictly parallel and show marked deviations
from linearity at high peroxide concentrations, particularly pronounced at low
cosubstrate levels. To some extent, that could also be observed with the
TrxC-dependent AhpC system. As is evident at least from the upper curves
in Fig. 3.10 A, the slope is clearly steeper at high hydroperoxide concentra-
tions. Qualitatively, the same phenomenon is seen in the curves obtained at
higher TrxC concentrations. Unfortunately, for technical reasons the two
phases of the curves could not be assessed with the same accuracy. Only
the flatter slopes observed over a wide range of lower hydroperoxide con-
centrations, could be used for further data processing. Accordingly, the Dal-
ziel coefficients and kinetic constants, obtained from the secondary plot (Fig.
3.10 B) and compiled in Table 3.1, ignore the deviations from the classical
ping-pong pattern at extreme substrate concentrations and thus, serve to
characterize the enzyme in its predominantly reduced conformation.
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Fig. 3.9: Steady-state-kinetic analysis of MtTPx with MtTrxB as cosubstrate. Sub-
strate turnover by MtTPx was monitored continuously by NADPH consumption in a cou-
pled test system at 25 ° C and pH 7.4 with t-bOOH as substrate and MtTrxB as cosub-
strate. Three sets of data were analyzed according to Dalziel (1957). Results are pre-
sented in terms of the general Dalziel-equation for two-substrate reaction ([Eo]/v = φ0 +
φ1/[ROOH] + φ2/[reductant]; see Table 3.1). (A) Example of primary Dalziel plot showing
enzyme-normalized inverse initial velocities ([E0]/v) dependent on the reciprocal hydro-
peroxide concentration at different MtTrxB concentrations, kept constant by continuous
regeneration. The slopes correspond to φ1. (B) Secondary Dalziel plot: The ordinate in-
tercepts of (A), i. e. the apparent maximum velocities at [A] = ∞, are plotted against
1/[MtTrxB] for evaluation of Dalziel coefficient φ2 (slope), limiting KM MtTrxB (abscissa inter-
cept is 1/KM MtTrxB) and real maximum velocities (ordinate intercept is φ0 = [E0]/Vmax). Pri-
mary data of three independent analyses, as shown in (A), were used to obtain means
and standard deviations.
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Fig. 3.10: Steady-state-kinetic analysis of MtTPx with MtTrxC as cosubstrate. Sub-
strate turnover by MtTPx was monitored continuously by NADPH consumption in a cou-
pled test system at 25 ° C and pH 7.4 with t-bOOH as substrate and MtTrxC as cosub-
strate. Three sets of data were analyzed according to Dalziel (1957). Results are pre-
sented in terms of the general Dalziel-equation for two-substrate reaction ([Eo]/v = φ0 +
φ1/[ROOH] + φ2/[reductant]; see Table 3.1). (A) Example of primary Dalziel plot showing
enzyme-normalized inverse initial velocities ([E0]/v) in dependent on the reciprocal hy-
droperoxide concentration at different MtTrxC concentrations, kept constant by continu-
ous regeneration. The slopes correspond to φ1. Note the biphasic slopes; only the flatter
parts were used for data processing. (B) Secondary Dalziel plot: The ordinate intercepts
of (A), i. e. the apparent maximum velocities at [A] = ∞, are plotted against 1/[MtTrxC] for
evaluation of Dalziel coefficient φ2 (slope) , limiting KM MtTrxC (abscissa intercept is
1/KM MtTrxC) and real maximum velocities (ordinate intercept is φ0 = [E0]/Vmax). Primary data
of three independent analyses, as shown in (A), were used to obtain means and stan-
dard deviations.
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As mentioned previously this kinetic anomaly has also been reported for
other oligomeric peroxiredoxins, and for MtAhpC in this study. The phe-
nomenon is interpreted as being indicative of negative cooperativity between
subunits. Gel permeation analyses of native MtTPx yielded an average size
of ~ 36 kDa for the oxidized and reduced enzymes, respectively, indicating
that two TPx monomers self-associate in solution independent of their redox
state (data not shown). The kinetic anomalies of MtTPx could thus be due to
allosteric phenomena as inferred for other oligomeric peroxiredoxins, and for
MtAhpC in this study.
The peroxidation efficiency of MtTPx is about one order of magnitude higher
than that of MtAhpC. With MtTrxB as cosubstrate a k′1 value 3.3 x 105 M-1s-1
was measured and that appears to be more reliable than the corresponding
value of 0.9 x 105 M-1s-1 obtained with MtTrxC. In a ping-pong mechanism,
the values should be identical but the latter is likely an underestimate due to
the deviations from linearity in the reciprocal plots (Fig. 3.10 A). The k′2 val-
ues of MtTPx for both thioredoxins are similar and slightly higher than
MtAhpC for MtTrxC but lower than the MtAhpC/MtAhpD combination. The
highest Vmax was obtained for the MtTPx/MtTrxC system.
Table 3.1: Kinetic constants of MtAhpC and MtTPx. Rate constants were derived from
steady-state analysis; the empirical Dalziel coefficients φ0, φ1 and φ2 correspond to the
reciprocal values of kcat, k′1 and k′2, the latter being net rate constants for the forward
reaction of the enzymes with t-bOOH and the reductants, respectively.
Enzyme Reductant kcat
 [s-1]
k’1
[M-1s-1]
k’2
[M-1s-1]
KM ROOH
[µM]
KM reductant
[µM]
MtAhpC MtAhpD 0.63 ± 0.10 0.95 x 104 ± 0.08 2.7 x 106 ± 1.43 65.65 0.23
MtAhpC MtTrxC 0.13 ± 0.00 2.3 x 104 ± 0.07 2.5 x 104 ±   0.12 5.64 5.10
MtTPx MtTrxB 0.66 ± 0.11 3.4 x 105 ± 0.48 4.6 x 104 ±   0.35 1.95 14.46
MtTPx MtTrxC 11.11 ± 0.10 0.9 x 105 ± 0.22 5.8 x 104 ±   0.22 120.68 184.48
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3.4 Specificity of MtAhpC and MtTPx for reactive oxygen and
nitrogen intermediates
Organic hydroperoxides, peroxynitrite (ONOO−), and other reactive nitrogen
and oxygen intermediates produced by macrophages play a role in host de-
fense against invading bacteria (Yu et al., 1999; Nathan and Shiloh, 2000;
Akaki et al., 2000; Darrah et al., 2000; Paziak-Domanska et al., 2000; Shiloh
and Nathan, 2000). Consequently, many bacterial pathogens have evolved
with protection mechanisms against reactive oxygen and nitrogen intermedi-
ates (Zahrt and Deretic, 2002).
Like other peroxiredoxins (Hofmann et al., 2002), also MtAhpC and MtTPx
reduced a variety of hydroperoxides including H2O2, yet MtAhpC was inac-
tive with phosphatidylcholin hydroperoxide (PCOOH) and MtTPx did not re-
duce linoleic acid hydroperoxide (LOOH). The percentage activities listed in
Table 3.2 may be considered to correspond to relative changes in k′1 values,
since they were obtained at identical concentrations of reductants.
Table 3.2: Specificity of MtAhpC and MtTPx for hydroperoxide substrates. The en-
zyme activities with t-butyl hydroperoxide (t-bOOH) were set to 100 %. LOOH, PCOOH
and COOH mean linoleic acid hydroperoxide, phosphatidylcholin hydroperoxide and cu-
mene hydroperoxide, respectively. *The activities with H2O2 were difficult to estimate due
to the basal activity of the TR/Trx system (see 2.7.4).
Enzyme Reductant t-bOOH LOOH PCOOH H2O2 COOH
MtAhpC MtTrxC (100) 30 0 140* 60
MtTPx MtTrxB (100) 0 6 150* 54
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MtAhpC also reduces peroxynitrite (Bryk et al., 2000), which is formed by
activated macrophages from ⋅O2− and ⋅NO (Alvarez et al., 2002) and partici-
pates in the oxide-dependent killing of M. tuberculosis (St John et al., 2001).
The k′1 value of MtAhpC for peroxynitrite was reported to be 1.33 x 106
M-1s-1. The reactivity of peroxynitrite with MtTPx, that can not be investigated
by steady-state kinetics due to its short half-life (< 1 s at pH 7.4; Radi et al.,
2000), was evaluated by stopped-flow techniques: Direct monitoring of per-
oxynitrite decay at 302 nm yielded the expected first order rate constant of
0.3 s-1. In the presence of 15 µM of reduced MtTPx at 25 ° C, the initial rate
of peroxynitrite reduction was too fast to be reliably measured but entire de-
cay curves reasonably complied with that calculated with second order rate
constant k′1 of 1.2 x 107 M-1s-1 (Fig. 3.11). This fast peroxynitrite reduction
was completely inhibited by NEM that is known to inhibit the peroxidatively
active thiol of peroxiredoxins (Nogoceke et al., 1997). An independent
measurement of k′1 for the reaction of MtTPx with peroxynitrite by stopped-
flow was obtained by measuring the competition with Mn3+ porphyrin, that
reduces peroxynitrite with a k′1 of 1.2 x 109 M-1s-1. The rate constant for
MtTPx/peroxynitrite interaction calculated therefrom was 1.5 x 107 M-1s-1 and
thus is the highest so far observed for any of the enzymes working with sul-
fur catalysis (Fig. 3.12).
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Fig. 3.11: Peroxynitrite reduction by MtTPx. Peroxynitrite (24 µM) decomposition in
100 mM sodium phosphate buffer, 0.1 mM DPTA, pH 7.4, either in the absence (control)
or in the presence of reduced MtTPx (15 µM) was followed at 302 nm. The continuous
line shows the computer-assisted simulated decay of peroxynitrite (24 µM) in the pres-
ence of 15 µM MtTPx assuming a value of 1.2 x 107 M-1s-1 for the apparent (pH-
dependent) second order rate constant between peroxynitrite and the enzyme. Devia-
tions at times longer than 20 ms reflect the reaction of peroxynitrite with targets in the
enzyme other than its reactive thiol (Ferrer-Sueta et al., 1999).
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Fig. 3.12: Competition of peroxynitrite-dependent Mn3+-TE-2-PyP oxidation by
MtTPx. (A) Mn3+-TE-2-PyP (7µM) was oxidized by peroxynitrite (2µM) in 50 mM sodium
phosphate buffer, 0.1 mM DPTA, pH 7.4 at 25 ° C in the absence or presence of different
MtTPx concentrations. (B) Plotting the initial rate of Mn3+-TE-2-Pyp oxidation against
MtTPx concentrations yields a hyperbolic function indicating 50 % inhibition by 5.7 µM
MtTPx. With the known rate constant for Mn3+-TE-2-PyP a k′1 value of the competing
MtTPx is therefrom calculated to be 1.5 x 107 M-1s-1
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4 Discussion
M. tuberculosis
 does not exhibit the classical oxidative stress responses,
with the oxyR regulator being absent from its genome (Deretic et al., 1995;
Deretic et al., 1997; Cole et al., 1998). In the absence of OxyR-regulated
defense, the catalase/peroxidase enzyme encoded by the katG gene has
been reported to be the only peroxide-inducible gene in M. tuberculosis. The
isoniazid-resistant strains of M. tuberculosis are especially susceptible to
oxidative damage due to a non-functional catalase/peroxidase. Therefore, in
the absence of a functional oxyR response and the malfunctional katG, the
tuberculosis bacilli are faced with an unusual situation of survival within the
host’s macrophages without an effective oxidative stress response. In these
strains of M. tuberculosis, the ahpC gene has been shown to be frequently
overexpressed (Wilson and Collins, 1996). AhpC has also been shown to be
vital for mycobacterial survival within macrophages (Wilson et al., 1998),
and is therefore an attractive drug target.
The second peroxidase system discovered and characterized in this study,
the TPx system, seems to play another leading role in peroxide detoxifica-
tion in M. tuberculosis, independent of isoniazid susceptibility, and therefore
it too represents an attractive drug target. Recent findings provide support
for the importance of an AhpC-independent peroxide detoxifying system like
the TPx system. It is likely that KatG, AhpC, and TPx participate in partially
overlapping defense activities, and that they undergo stage-specific and/or
tissue-specific expression with compensatory activities, as previously noted
(Musser, 1995; Sherman et al., 1996; Dhandayuthapani et al., 1996; Heym
et al., 1997; Wallis et al., 1999; Wallis et al., 2000; Master et al., 2001). The
absence of oxyR, the silencing of ahpC, and its differential expression and
infection-stage-specific induction (Springer et al., 2001) most likely reflect
adaptations of various aspects to the infectious cycle of M. tuberculosis. For
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example, upon transmission to a new host or possibly during initial stages of
reactivation from latent infection, the stationary-phase M. tuberculosis
probably infects naïve, resting monocytes where AhpC may play a role in
resistance to the very early, innate cidal mechanisms of macrophages
(Master et al., 2002). Once IFN-γ and other protective cytokines become
available, AhpC may play a minor role, as indicated by the loss of differential
survival between ahpC+ and ahpC− cells in macrophages (Springer et al.,
2001; Master et al., 2002). Thus, at that stage TPx systems may play the
lead role in peroxide detoxification.
4.1 AhpC and TPx: Members of the peroxiredoxin family
AhpC and TPx are members of the ubiquitous peroxiredoxin (Prx) family
within the thioredoxin superfamily of protein folds. Prxs form a family of per-
oxidases that act on a variety of hydroperoxides using thiols as co-
substrates. Until now they were reported to be comprised of glutathione,
thioredoxin, tryparedoxin, or the CXXC motifs of bacterial AhpF and AhpD.
With most bacterial Prxs, disulfide reduction is achieved by the specialized
electron donor AhpF (Poole et al., 2000). In comparison many other Prx
systems (both bacterial and eukaryotic), including the AhpC and TPx sys-
tems described in this study, receive electrons from a reducing system com-
posed of thioredoxin and thioredoxin reductase (Hofmann et al., 2002; Wood
et al., 2003a). To detoxify peroxides, the reduced N-terminal Cys (peroxida-
tic cysteine), which is conserved in all Prxs, attacks the peroxide -O−O-
bond, with concomitant formation of a cysteine sulfenic acid (Cys−SOH) in-
termediate,
Cys−S−  + H+ + ROOH → Cys−SOH + ROH.                                               (7)
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It then condenses with a conserved C-terminal Cys (resolving cysteine) to
regenerate the stable disulfide bond at the active site (Poole and Ellis, 2002;
Baker and Poole, 2003)
Cys−SOH + RSH → Cys−S−SR + H2O.                                                      (8)
Prxs are divided into three classes: typical 2-Cys Prxs; atypical 2-Cys Prxs;
and 1-Cys Prxs. All Prxs share the same basic catalytic mechanism, in
which an active-site cysteine (the peroxidatic cysteine) is oxidized to a sul-
fenic acid by the peroxide substrate. The recycling of the sulfenic acid back
to a thiol is what distinguishes the three enzyme classes.
The typical 2-Cys Prxs are the largest class of Prxs and are identified by the
conservation of their two redox-active cysteines, the peroxidatic cysteine
(generally near residue 50) and the resolving cysteine (near residue 170)
(Hofmann et al., 2002). Typical 2-Cys Prxs are obligate homodimers con-
taining two identical active sites (Hirotsu et al., 1999; Alphey et al., 2000;
Schroeder et al., 2000; Wood et al., 2002). In the second step of the peroxi-
dase reaction, the peroxidatic cysteine sulfenic acid from one subunit is at-
tacked by the resolving cysteine located in the C-terminus of the other sub-
unit. This condensation reaction results in the formation of a stable intersub-
unit disulfide bond, which is then reduced by one of several cell-specific di-
sulfide oxidoreductases (e.g. thioredoxin, AhpF, tryparedoxin or AhpD
(Nogoceke et al., 1997; Poole et al., 2000; Bryk et al., 2002)), completing the
catalytic cycle.
The second class of Prxs are the atypical 2-Cys Prxs, which have the same
mechanism as typical 2-Cys Prxs but are functionally monomeric (Seo et al.,
2000; Declercq et al., 2001; Baker and Poole, 2003). In these Prxs, both the
peroxidatic cysteine and its corresponding resolving cysteine are contained
within the same polypeptide, with the condensation reaction resulting in the
formation of an intramolecular disulfide bond. Although the resolving cys-
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teines of typical and atypical 2-Cys Prxs are not conserved in sequence,
they are functionally equivalent.
The last class of Prxs, the 1-Cys Prxs, conserve only the peroxidatic cys-
teine and do not contain a resolving cysteine (Choi et al., 1998). Their cys-
teine sulfenic acid generated through reaction with peroxides is presumably
reduced by a thiol-containing electron donor. In few examples, the donor has
been shown to be glutathione (GSH) (Hofmann et al., 2002), but the identity
of the redox partner is not yet clear in most cases.
4.2 AhpC and TPx homologues
AhpC has sequence homology to the two cysteine containing AhpC proteins
from other organisms and seems to belong to the typical 2-Cys Prxs. It has a
higher similarity to the Gram-positive (M. bovis, M. smegmatis, Corynebacte-
rium diphtheriae, and Streptomyces viridosporus) than to the Gram-negative
(E. coli, S. typhimurium, Bacillus subtilis, and Staphylococcus aureus) AhpC
proteins. Interestingly the M. tuberculosis AhpC possesses three Cys resi-
dues, two located in close vicinity in the C-terminal region, at positions 174
and 176. The conserved N-terminal Cys residue is located at position 61.
Both the Cys-174 and Cys-176 residues can form a disulfide bond with the
conserved N-terminal Cys residue (Chauhan and Mande, 2001) and all the
three Cys residues are important for activity. Cys-61 and Cys-174 play a
critical role but Cys-176 is also involved in the catalytic cycle (Hillas et al.,
2000; Chauhan and Mande, 2002).
Homologues of TPx are distributed throughout most or all Gram-positive and
Gram-negative bacteria, but biochemical analyses have been limited pri-
marily to E. coli TPx. EcTPx is part of an oxidative stress defense system
that uses equivalents from thioredoxin and thioredoxin reductase to reduce
alkyl hydroperoxides. TPx homologues typically contain three Cys residues,
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Cys-93, Cys-80, and Cys-60 in MtTPx, and the latter residue aligns with the
N-terminal active site Cys of other peroxidases in the Prx family.
4.3 Structural and conformational properties of MtAhpC and
MtTPx
AhpC and TPx are both members of the Prx family; however, the two M. tu-
berculosis
 Prx members are highly divergent from one another and are rep-
resentatives of two distinct Prx subfamilies: typical 2-Cys Prxs (MtAhpC),
and atypical 2-Cys Prxs (MtTPx) (Hofmann et al., 2002; Wood et al., 2003a).
Generally, the active site of typical 2-Cys Prxs contains a disulfide bond
composed of a conserved N-terminal Cys (Cys-46 from S. typhimurium
AhpC) and the C-terminal Cys (Cys-165 from S. typhimurium AhpC) from the
other subunit of the parallel, but directionally opposite, dimer (Ellis and
Poole, 1997). Crystal structures of reduced (tryparedoxin peroxidase from
Crithidia fasciculata), oxidized (HBP23 from rat) and overoxidized (TPxB
from human) typical 2-Cys Prx homologues showed that reduction of the di-
sulfide bridge induces a conformational change in the quarternary structure
from a dimeric to a decameric form or vice versa (Hirotsu et al., 1999; Al-
phey et al., 2000; Schroeder et al., 2000). Although oligomerization seems to
be a general property of 2-Cys Prxs, the in vivo parameters inducing oli-
gomerization and its function are unknown. Low or high ionic strength, acidic
pH, and reducing or oxidizing conditions are reported to promote oligomeri-
zation but differ in their effects upon various 2-Cys Prxs (Chauhan and
Mande, 2001; Wood et al., 2002; Budde et al., 2003; König et al., 2003). Gel
permeation analyses and electron microscopy studies provide evidence for a
redox-dependent process in M. tuberculosis AhpC whereby reduced decam-
ers disassociate very rapidly into dimers upon oxidation. That was also re-
ported for S. typhimurium AhpC (Wood et al., 2002). A facilitated interaction
of MtAhpC with its reductant MtAhpD due to redox-dependent conforma-
4 - DISCUSSION 69
tional changes and ‘activation’ could explain the unsual lag phase in time
progression curves (see Fig. 3.4).
Atypical 2-Cys Prxs like MtTPx are proposed to be functionally monomeric
(Declercq et al., 2001). For the E. coli homologue of TPx it was reported that
it does not form the hallmark intersubunit disulfide linkage of typical 2-Cys
Prxs, and instead Cys-61 (Cys-60 from MtTPx) links with Cys-95 (Cys-93
from MtTPx) through an intra-molecular disulfide bond. Cys-95 participates
as a disulfide partner and is functionally equivalent to the resolving cysteine
that resides in another subunit of the more common typical 2-Cys Prxs.
Based on the structural data of C. fasciculata TXNPx (Hofmann et al., 2001)
and other peroxiredoxins (Hirotsu et al., 1999; Schroeder et al., 2000) a
model of TPx from M. tuberculosis was created, which provides evidence for
a similar mechanism for MtTPx (Fig. 4.1). Gel permeation analyses revealed
a homodimeric nature of MtTPx, as was also shown for EcTPx by ultracen-
trifugation analyses (Baker and Poole, 2003). 1-Cys Prxs are also function-
ally monomeric, but form homodimers at protein concentrations > 1 mg/ml
(Choi et al., 1998) and therefore, the formation of MtTPx dimers could occur
due to high protein concentration. In conclusion, unlike the more common
typical 2-Cys Prxs, which operate by an intersubunit disulfide mechanism,
MtTPx contains a redox-active intrasubunit disulfide bond yet is homodi-
meric in solution.
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Fig. 4.1: Model of MtTPx (upper panel) and a TPx/Trx catalytic intermediate (lower
panel). Upper panel: Conformation of oxidized MtTPx, as modeled into the structure of
C. fasciculata TXNPx. The intramolecular disulfide bond is shown as balls and sticks.
Lower panel: Model of a catalytic intermediate demonstrating potential TPx/Trx interac-
tions. The solvent exposed C34 of the MtTrxC (ribbon diagram) has reacted with the ac-
cessible C93 (resolving cysteine) of the MtTPx. Surface charges are shown in red (nega-
tive) and blue (positive), residue designations in red.
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The kinetic analyses of the TrxC/AhpC and TrxC/TPx system did not comply
with a simple ping-pong mechanism, as is common for peroxidases. In other
words, oxidation of the enzyme by the hydroperoxide substrate followed by
an independent reaction with the reductant (Dalziel, 1957; Ursini et al., 1995;
Flohé and Brigelius-Flohé, 2001; Hofmann et al., 2002). Particularly intrigu-
ing were deviations from linearity in the double-reciprocal plots (Fig. 3.8 A;
Fig. 3.10 A). Such irregularities had already been reported for the kinetic be-
haviour of the mitochondrial TXNPx of Leishmania infantum (Castro et al.,
2002) and the TXNPx of Trypanosoma brucei brucei (Budde et al., 2003). In
those cases, the phenomenon was interpreted as negative cooperativity
between subunits. Our kinetic and morphological data support the concept of
negative cooperativity to be valid also for MtAhpC and MtTPx. Taking into
account the growing number of Prxs with an irregular kinetic behaviour, not
following strictly linear Lineweaver-Burk or Dalziel plots might rather be the
rule than the exception for Prxs.
It remains an intriguing question as to what extent the cooperativity concept
may be extended to other 2-Cys Prxs. Certainly there are qualitative differ-
ences: with TXNPxs of L. infantum and T. brucei brucei, for instance, a dimer
to decamer transition was reported to be induced by oxidation (Castro et al.,
2002; Budde et al., 2003). In contrast, with AhpC of M. tuberculosis and S.
typhimurium
 (Wood et al., 2002) the decamer is stabilized by reduction. In
general, however, the 2-Cys Prxs qualify as potentially cooperative proteins.
Since the early conceptual thoughts as to why proteins form oligomers that
communicate with each other, cooperativity has been considered as a tool
for metabolic regulation (Monod et al., 1965; Koshland, 1970; Stadtman,
1970). The Prxs appear to support that view. If not in control of peroxide
detoxification Prxs are evidently involved in regulating signaling cascades or
metabolic processes (Hofmann et al., 2002; Wood et al., 2003b). The evi-
dent cooperative potential of the Prxs deserves particular attention when the
biological function of this novel family of proteins is to be explored.
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4.4 Physiological relevance of the MtAhpC and MtTPx systems
The kinetic constants compiled in Table 3.1 and derived from Fig. 3.11 and
Fig. 3.12 allow the estimation of turnover rates for the different mycobacte-
rial peroxidase systems (Fig. 4.2), by means of the general rate equation for
two-substrate ping-pong mechanisms,
[E0]/v = φ0 + φ1/[ROOH] + φ2/[reductant]                                                       (9)
if, as a first approximation, the peculiarities of peroxiredoxin kinetics at ex-
treme substrate concentrations are ignored. Unfortunately, however, the
concentrations of the enzymes appear to vary between strains and substrate
concentrations can only be roughly estimated. At low peroxide level and high
supply of reductants, as is commonly assumed for unstressed situations, the
turnover depends on the level of reduced peroxidase that should approxi-
mately equal [E0], on k′1 and on the peroxide concentration
v = k′1 [Ered] [ROOH].                                                                                 (10)
AhpC is hardly detected in most of the katG+ strains of M. tuberculosis and
M. marinum, but is easily found in M. smegmatis and M. bovis BCG. In con-
trast, MtTPx is consistently seen in proteomes of M. tuberculosis. Its con-
centration may be estimated to be much higher than AhpC (Pagan-Ramos et
al., 1998; Jungblut et al., 1999; Mollenkopf et al., 1999; Springer et al.,
2001). Being the dominant peroxiredoxin and having a higher k′1 than AhpC,
MtTPx may definitely be rated as the more relevant enzyme.
Under H2O2 stress the reductant capacity may become limiting according to
v = k′2 [Eox] [reductant].                                                                              (11)
The concentration of the reductants is linked in a complex manner to the
NADH and NADPH pools and depends on the speed of regenerating en-
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zymes and the pool size of the reductant, only the latter being easily esti-
mated. AhpD is identifiable in M. tuberculosis proteomes as a minor spot
corresponding to a low molarity level. In comparison, MtTrxB, although
known by its sequence and characterized here as a specific substrate of
MtTPx, so far could not be identified in proteomes. To the contrary, MtTrxC
is always seen as a major protein in all M. tuberculosis strains investigated.
MtTR is a medium spot in all mycobacterial proteomes analyzed (Nagai et
al., 1991; Sonnenberg and Belisle, 1997; Weldingh et al., 1998; Jungblut et
al., 1999; Mollenkopf et al., 1999; Rosenkrands et al., 2000a; Rosenkrands
et al., 2000b). Thus, because of their high reduction capacities, the
MtTR/TrxC-mediated detoxification systems should become particularly
relevant under conditions of oxidative stress.
Considering both rate constants and capacities, NADPH-driven H2O2 reduc-
tion by the MtTR/MtTrxC/MtAhpC and the MtTR/MtTrxC/MtTPx systems
should be at least as efficient as the NADH-driven, AhpD/AhpC-mediated
system in coping with H2O2 challenge in katG− strains. Both peroxiredoxin-
type peroxidases, however, may also satisfy special antioxidant require-
ments in katG+ strains by acting on a broad spectrum of hydroperoxides.
MtAhpC reduces complex lipid hydroperoxides with complementary efficien-
cies and MtTPx can even compete with catalase in peroxynitrite reduction
(Table 3.2; Fig. 3.11 and Fig. 3.12). Therefore, both MtAhpC and MtTPx
complement catalase in antioxidant defense of M. tuberculosis as do broad
spectrum selenoperoxidases, such as GPx-1, in the host (Flohé and Bri-
gelius-Flohé, 2001; Fig. 4.2 A), where the peroxiredoxins fall short in cata-
lytic efficiencies and are more likely involved in specific redox regulation of
metabolic processes (Hofmann et al., 2002; Wood et al., 2003b). In myco-
bacteria, being devoid of the GSH-dependent detoxification system, the per-
oxiredoxins should significantly contribute to the pathogen’s resistance to the
oxidative and nitrosative stress exerted by the innate immune response.
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Fig. 4.2: Hydroperoxide detoxifying systems in M. tuberculosis. (A) The main route of
mammalian hydroperoxide reduction is shown for comparison. (B) NADPH-driven hydro-
peroxide reduction by AhpC, mediated by TR and TrxC. (C) NADH-driven and AhpD-
mediated hydroperoxide reduction by AhpC according to Bryk et al. (2002). (D) NADPH-
driven hydroperoxide reduction by TPx, mediated by TR and TrxB or TrxC, respectively.
AhpC, alkyl hydroperoxide reductase subunit C; AhpD, alkyl hydroperoxide reductase
subunit D; GPx-1, type-1 glutathione peroxidase; GR, glutathione reductase; GSH, glu-
tathione; GSSG, oxidized glutathione; Lpd, dihydrolipoamide dehydrogenase; SucB, di-
hydrolipoamide succinyltransferase; TPx, thiol peroxidase; TR, thioredoxin reductase;
Trx, thioredoxin.
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4.5 AhpC and TPx are potential drug targets
Tuberculosis has re-emanated as a growing global health problem not only
because of the lack of proper therapeutic agents for its treatment but also
due to the development of drug-resistant strains. The disease still continues
its ravenous journey across the world killing young and middle-aged adults
faster than any disease other than AIDS. Despite the widespread use of the
bacillus Calmette-Guérin vaccine and the availability of antibiotics against
M. tuberculosis, it is estimated that in 1997 there were approximately eight
million new cases of tuberculosis and nearly two million deaths due to the
disease (Dye et al., 1999). The emergence of MDR strains of the deadly
pathogen render the current mode of treatment very difficult and in many
cases completely ineffective. Thus, newer and more efficient anti-TB drugs
are desperately needed. The unravelling of the M. tuberculosis genome se-
quence (Cole et al., 1998), gives new dimensions to anti-TB drug research.
It has initiated a hunt for genes of interest either for vaccine development, as
candidates for protective antigens or as molecular targets to screen for in-
hibitors that might prove useful as antituberculous drugs. New methods for
identifying the enzymes/proteins involved in essential biochemical pathways
of M. tuberculosis are now available. The discovery of novel hydroperoxide
detoxifying pathways in the present study is a promising example of how to
make use of genome information. A better understanding of the underlying
molecular mechanisms of M. tuberculosis virulence and pathogenicity will
hopefully lead to the development of new therapies against tuberculosis.
In my view, there are two main ways to approach the identification of poten-
tial new drug targets from the TB genome:
•
 To select for targets that are conserved amongst different species of
bacteria but poorly conserved or alternatively unconserved in humans.
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Targeting such molecules may lead to broad-spectrum antimicrobial
agents.
•
 To identify potential targets that are unique to M. tuberculosis for devel-
oping specific anti-TB drugs.
In the present study the second approach was pursued. The different peroxi-
dase systems described here were discovered by systematic screening of
the M. tuberculosis genome sequence for homologues of AhpF, thioredoxin-
related proteins and peroxiredoxins. The isolated gene products were func-
tionally analyzed and tested with regard to the relevance for mycobacterial
peroxide detoxification. The in vitro recombination of the gene products re-
sulted in two novel redox cascades. Due consideration of the in vivo con-
centrations of the participating enzymes and their kinetic efficiency, qualify
the thioredoxin-dependent AhpC and TPx systems as relevant ones.
Thereby, MtAhpC and MtTPx, and their supportive enzymes MtTR and
MtTrxC, deserve interest as potential targets for the design of anti-TB
agents. Specific inhibitors of those enzymes should have tuberculostatic or
even tuberculocidal effects and could serve as a powerful tool in fighting
against INH-resistant and/or MDR strains.
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5 Summary
Drug resistance and virulence of M. tuberculosis are in part related to the
pathogen’s antioxidant defense systems. KatG− strains are resistant to the
first line tuberculostatic isoniazid but they need to compensate their catalase
deficiency by alternative peroxidase systems to remain virulent. So far only
NADH-driven and AhpD-mediated hydroperoxide reduction by AhpC has
been implicated as such a virulence-determining mechanism. In search of
more likely metabolic links of AhpC, the genome of M. tuberculosis was
screened for homologues of AhpF, thioredoxin-related proteins and per-
oxiredoxins. The genes were expressed heterologously in E. coli or M.
smegmatis
 and purified to homogeneity. By means of those tools, two novel
pathways were discovered that underscore the importance of the thioredoxin
system for antioxidant defense in M. tuberculosis. They are: (1) NADPH-
driven hydroperoxide reduction by AhpC that is mediated by thioredoxin re-
ductase and thioredoxin C and (2) hydroperoxide reduction by the atypical
peroxiredoxin TPx that equally depends on thioredoxin reductase but can
use both thioredoxin B and C. According to kinetic analyses of hydroperox-
ide and peroxynitrite reduction and estimated enzyme levels, the redox cas-
cade comprising thioredoxin reductase, thioredoxin C and TPx should be the
most efficient system in situ to protect M. tuberculosis against oxidative and
nitrosative stress.
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7 Appendix
7.1 Abbreviations
0 0
ngström
Ax absorption at x nm
AhpC alkyl hydroperoxide reductase subunit C
AhpD alkyl hydroperoxide reductase subunit D
AhpF alkyl hydroperoxide reductase subunit F
AIDS aquired immune deficiency syndrome
AFB acid-fast bacilli
APS ammoniumperoxodisulfate
ATCC American Type Culture Collection
bp base pair
BCG Bacille Calmette Guérin
BD Becton Dickinson
BSA bovine serum albumine
COOH cumene hydroperoxide
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Da Dalton
deion deionized
dest destilled
DNA deoxyribonucleic acid
dNTP deoxyribonucleoside triphosphate
DOTS directly observed treatment short-course
DPTA diethylene-triamine-pentaacetic acid
DSMZ German Culture Collection of Microorganisms and Cell
Cultures
DTT dithiothreitol
Ex extinction at x nm
Ec Escherichia coli
EDTA ethylenediaminetetraacetic acid
EFTEM energy-filtered transmission electron microscope
Fig figure
GBF German Research Centre for Biotechnology
GPx-1 type-1 glutathione peroxidase
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GR glutathione reductase
GSH glutathione
HBP23 heme binding protein 23 kDa
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HIV human immunodeficiency virus
HSP heat shock protein
i.e. in example
IFN-γ interferon-γ
INH isoniazid
InhA/inhA acyl carrier protein-enoyl reductase
IPTG isopropyl-β-D-thiogalactopyranoside
KatG/katG catalase peroxidase
kDa Kilodalton
LB Luria Bertani medium
LOOH 13-hydroperoxy octodecadienoic acid hydroperoxide
Lpd dihydrolipoamide dehydrogenase
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LT-α3 lymphotoxin-α3
MALDI-TOF matrix-assisted laser desorption and ionization time-of-
flight
MDR multi-drug-resistant
MIC minimum inhibiting concentration
Mn3+-TE-2-PyP Mn3+-meso-tetrakis[(N-ethyl)pyridinium-2-yl]porphyrin
MSB master seed bank
Mt Mycobacterium tuberculosis
MycR mycothiol reductase
MSH mycothiol
NADH nicotinamide adenine dinucleotide
NADPH nicotinamide adenine dinucleotide phosphate
Ndh/ndh NADH dehydrogenase
NEM N-ethylmaleimid
NTA nitrilotriacetic acid
ODx optical density at x nm
ORF open reading frame
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OxyR/oxyR oxidative stress regulator
PAGE polyacrylamide gel electrophoresis
PCOOH phosphatidylcholin hydroperoxide
PCR polymerase chain reaction
Prx peroxiredoxin
PVDF polyvinylidendifluoride
RMP rifampin/rifampicin
RNI reactive nitrogen intermediates
ROI reactive oxygen intermediates
rpm rounds per minute
RT room temperature
SDS sodium dodecyl sulfate
SucB dihydroliponamide succinyl-transferase
TB tuberculosis
TBE tris-borate EDTA
t-bOOH tert-butyl hydroperoxide
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TEMED N,N,N’,N’-tetramethylethylenediamine
TNF-α tumour-necrosis factor-α
TPx thiol peroxidase
TR thioredoxin reductase
Trx thioredoxin
TXNPx tryparedoxin peroxidase
UNAM Universidad Nacional Autónoma de México
vol volume
WHO World Health Organization
7.2 Abbreviations of nucleotides and amino acids
Table 7.1: Abbreviations of nucleotides
nucleotide abbreviations
adenine A
cytosine C
guanine G
uracile U
thymine T
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Table 7.2: Abbreviations of amino acids
amino acid 1 letter code 3 letter code
alanine Ala A
arginine Arg R
asparagine Asn N
aspartic acid Asp D
cysteine Cys C
glutamine Gln Q
glutamic acid Glu E
glycine Gly G
histidine His H
isoleucine Ile I
leucine Leu L
lysine Lys K
methionine Met M
phenylalanine Phe F
proline Pro P
serine Ser S
threonine Thr T
tryptophan Trp W
tyrosine Tyr Y
valine Val V
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